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INTRODUCTION 
Intrauterine growth restriction is one of the major complications of 
pregnancy affecting 5-10 %  of all gestation. It causes increased 
morbidity and mortality in perinatal period and in infancy. The adverse 
consequences of fetal growth restriction extend beyond early years into 
later life. Prof. David Barker pioneered the concept of developmental 
programming & has stimulated tremendous research into the origin of a 
spectrum of cardiovascular and metabolic disorders in adults. But the 
exact causes of intrauterine growth restriction still remains unclear. 
Antenatal fetal surveillance identifies fetuses at risk of IUGR to offer 
them close monitoring to prevent  perinatal mortality & morbidity & long 
term consequences. 
Restriction in growth implies failure of the fetus to realize its genetically 
endowed growth potential. Growth potential determination of  an 
individual fetus however remains difficult. Many studies produced 
normative gestational age specific birth weight standards that have been 
used to define retrospectively suboptimal fetal growth. Before the 
introduction of ultrasound, prospective measurement of fetal growth  has 
been limited to measuring uterine size and guessing fetal size by 
palpation. Over the last few decades, ultra sonogram & Doppler has come 
into play a major role in evaluation of fetal growth in utero. 
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DEFINITION : 
IUGR can be defined as a condition in which  the fetus fails to achieve its 
genetic growth potential. A fetus is considered growth restricted when 
ultrasonographically measured fetal dimensions particularly AC or EFW 
from multiple biometric measurements, below a certain gestational age 
specific threshold. The most commonly used threshold is 10
th
 percentile. 
This standard is arbitrary & it may lead to misdiagnosis of growth 
restriction. A more rigorous threshold such as 5
th
 or 3
rd
 percentile would 
be more specific but it is less sensitive. 
CLASSIFICATION OF IUGR; 
There are 3 types of IUGR based on time of onset & the pathological 
process. 
TYPE 1 OR SYMMETRIC OR  INTRINSIC IUGR: 
Accounts for 20-30% of IUGR. 
Due to growth inhibition early in pregnancy. 
All parameters like  BPD/HC/AC/EFW are below 10
th
 percentile & 
they have normal Ponderal index. 
Causes are mainly Infection in utero (HERPES SIMPLEX, 
RUBELLA, CYTOMEGLO VIRUS, TOXOPLASMOSIS) Chromosomal 
disorders & congenital malformation. 
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Any insult in early phase of fetal development (4-20 wks) result in 
reduced number of cells in the fetus & overall reduction in growth 
potential. 
These babies may not have immediate effect but they are at risk of 
long term complications like neuro developmental dysfunction. 
TYPES 2 OR ASYMMETRIC IUGR: 
Accounts for 70-80% of IUGR. 
Due to placental insufficiency resulting from maternal condition or 
placental pathology. 
Onset usually after 28 weeks. 
In USG, BPD, HC remains normal, but AC &Ponderal index are low due 
to redistribution of blood flow from periphery to Brain and Heart. 
These babies are at great risk of antepartum and intrapartum 
complications as well as neonatal morbidity and mortality. Moreover 
timely identification and interventions can reduce these complications. 
TYPE 3 OR INTERMEDIATE IUGR: 
Accounts for 5-10 % of IUGR. 
Combination of Type 1 & Type 2 IUGR. 
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With this background this study has been conducted to know about 
the predictive value of placental volume& placental bed vascularity that 
is measured antenatally by  ultrasound over the adverse prenatal outcome 
of the IUGR fetuses. 
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AIM OF THE STUDY 
 
1. To estimate the placental volume& placental bed 
vascularity by ultrasound. 
2. To estimate the placental volume immediately following 
delivery. 
3. To estimate the placental volume measured before 
delivery by ultrasound with that of measured after 
delivery. 
4. To estimate the placental volume & placental bed 
vascularity in IUGR and NORMAL pregnancy. 
5. To correlate the adverse perinatal outcome with placental 
volume &placental bed vascularity in IUGR pregnancy. 
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REVIEW OF LITERATURE 
Fetal weight is determined by the genetic growth potential, the health of 
the fetus, the capacity of the mother to supply adequate substrate for 
growth and the ability of the placenta to transport the substrates to the 
fetus. Hence placenta acts as a vector for all nutrient exchange between 
the mother and the fetus &it has principle influence on the birth weight of 
the fetus. 
DIAGNOSIS OF IUGR: 
IUGR is suspected in patients with risk factors like low prepregnancy 
BMI, preeclampsia, chronic renal disorders ,vasculopathy, infections. 
Gestational age determination is the most important  in  diagnosis of 
IUGR. 
1. Clinical method:  Measurement of symphysio fundal height  & 
abdominal circumference are the most common clinical methods. 
Symphysio fundal height increases by 1 cm/ wk& it  coincides with  
gestational age between 18-30weeks.Lag of fundal height of 4 wks 
is suggestive of moderate IUGR &lag of > 6 wks is suggestive of 
severe IUGR. when used alone this method has low sensitivity. 
Both RCOG and ACOG recommend this simple technique to find 
abnormal growth. ACOG suggests that symphysio fundal height 
measurement at 32-34 weeks has 70-85 % sensitivity and 96% 
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specificity in detecting IUGR. Whereas RCOG suggest that it has 
27% sensitivity and 88% specificity in detecting IUGR. 
Bakketeig et al (1984)
1
 compared  clinical method and sonographic 
study and concluded the detection rate of IUGR for these two 
groups was similar (25% for ultrasound and 11 % for 
symphysiofundal height; RR 1.36, 95% CI 0.1.99) 
2. ULTRASONOGRAM :Several parameters  are used in diagnosis 
of IUGR.Among them AC has highest sensitivity and greatest 
negative predictive value. An increase in AC less than 10mm in 2 
wks has 85% sensitivity and 74 % specificity in detecting IUGR. 
Various age independent morphometric ratios like HC/AC/FL/AC 
has also been used in detection of IUGR. 
Mckenna et al (2003)
2
done and studied ultrasound examination of  
patients consisting of Estimated fetal weight, Amniotic fluid index 
and placental grade at 30-32 weeks and 36-37 weeks and clinical 
methods like symphysiofundalheight alone. They reported  the 
prevalence of IUGR was  lower in ultrasound examination (7%) 
than with clinical method (10%), (95% cI 0.50-0.89). 
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3. Doppler velocimetry : Doppler has poor sensitivity in detecting 
IUGR. But the Doppler changes related well with  outcome of the 
fetus. Alteration in blood flow velocimetry of umbilical arteries is 
an early predictor of IUGR. Ductus Venosus flow alteration is an 
accurate predictor of acidemia. 
In idiopathic IUGR where there are no obvious fetal and  maternal 
causes, the placenta might the etiology. Various authors recorded 
contradictory histological and morphological findings while 
comparing the placenta of IUGR Pregnancies to that normal 
pregnancies. 
ETIOLOGY OF IUGR : 
Numerous maternal, fetal and placental disorders may interfere with 
normal mechanisms and affects fetal growth resulting in IUGR. 
MATERNAL FACTORS : 
1. Maternal hypertensive disorders: 
Hypertensive disorders present in 30-40% of  IUGR 
pregnancies. Pre eclampsia, chronic hypertension, preeclampsia, 
autoimmune disorder, nephropathy, presentational diabetes are 
associated with maternal vasculopathy  leads to fetal growth 
restriction. 
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According to Odegardvattern / Nilsen et al (2000)
10
 
preeclampsia has  4 fold increase of having IUGR babies (RR= 4.2; 
95% CI2.2-8.0). 
The severe preeclampsia and the early  onset of pre eclampsia 
associated with  low birth weight. Long, abel, Beisher (1980)
11
 reported 
that, Low birth weight was 5% in mild pre eclampsia (95%  CI 3- 6) & 
12% with severe disease (95% CI 9-15) and it is was 23% with early 
onset disease ( 95% CI 18-29). There is evidence that elevated diastolic 
blood pressure withoutproteinuriais associated with small for gestational 
age but risk is lower than that of proteinuric hypertension. According to 
Sibai (2002)
12
 there is variable increase in small for gestational age 
infants with mild chronic hypertension in pregnancy (8-15.5%) 
Proteinuria occurring in early pregnancy is associated with elevated risk 
of fetal growth restriction (OR 2.8; 95% CI 1.6-5.0). 
Moreover maternal antihypertensive therapy fails to improve fetal 
growth and some beta blockers like Atenolol increases the risk of IUGR . 
2. Maternal autoimmune disorders: 
Maternal autoimmune disorders especially with vascular 
involvement are associated with adverse perinatal  outcome. 
Patients with antiphospholipid antibody syndrome shows 
significant increase in stillbirth. 
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SLE in pregnancy is associated with 3 fold increase in fetal death 
when APLA is positive. 
In a prospective study by Yasudha, Takakuwa, Tokunaga et al (1995) 
the relative risk of growth restriction with positive APLA was 6.22 % (95 
% CI 2.43-16). 
3. Thrombophilia : 
There is controversy in association between IUGR and maternal 
Thrombophilia.Howley/walker/Rodger(2005)
14
 done meta analysis of 10 
case control studies.They showed a significant association between IUGR 
and presence of factor v leiden mutation (OR 2.7; 95% CI 1.3-5.5) & 
prothrombin gene variant (OR 2.5; 95% CI 1.3-5). The relationship 
between methylene tetra hydrofolate reductase mutation and IUGR still 
remains unsubstantiated. 
4. Maternal life style : 
Maternal use of  recreational drugs& addictive substances  
associated with IUGR. However causal relationship is difficult to 
establish  due to other associated confounding factors like malnutrition, 
multiple substance abuse, street and other lifestyle variables. 
Maternal smoking is associated with fall in EFW due to the carbon 
monoxide which interferes with fetal oxygenation and the 
vasoconstrictive property of nicotine/Kramer ms (1987)
15
. 
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Cliver et al (1995) noted  average birth weight reduction of 6% when 
smoking was continued throughout gestation compared with only 1.7 % 
when it was stopped after 1
st
 trimester and this effect  appeared to be dose 
dependent and also increased by other cofactors like hypertension. 
Cnattingius, Mills et al (1997)
17
 showed increased incidence of 
small for gestational infant when smoking is associated with hypertension 
than not associated with hypertension (40% vs 5%). 
Taking alcohol even 1 drink per day is associated with IUGR and low 
Apgar at birth (windham et al 1995)
18
. 
Cocaine use in pregnancy is also associated with  maternal and fetal 
effects including  maternal stroke, cardiac arrhythmia, hypertension, 
placental abruption, fetal brain injury and still birth. 
5. Therapeutic agents : 
Antineoplastic agents, anticonvulsants such as phenytoin, Beta 
blockers and steroids are associated  with IUGR. 
6. Malnutrition : 
The effect of maternal malnutrition on fetal growth depends on the 
severity of deprivation & the period of gestation. 
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7. Environmental pollution 
Epidemiological investigations on the impact of environmental 
pollution on pregnancy outcome shows slight increase in the frequency of 
IUGR (Maisonet, Coree, Misra et al 2004)
19
 
This  effect was discernible even with relatively low concentration 
of gaseous pollutants such as So2, No2, CO, Ozone (Liu et al 2003)
20
. 
FETAL FACTORS: 
1. Aneuploidy : 
Fetal chromosomal anomaliesare strongly associated with IUGR. 
About 7% of IUGR attributable to aneuploidy. 
Early growth restriction is associated with increased odds of 
trisomy 18 & trisomy 13 (Bagadosingh et al 1997)
21
. 
90 % of trisomy 18 are associated with IUGR when compared to 
30% in trisomy 21. 
Fetuses with aneuploidy is associated with increased incidence of 
fetal malformations that leads to higher frequency of somatic asymmetry, 
increased or  decreased amniotic fluid volume and normal Doppler 
indices of umbilical and/or uterine artery. 
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2. Genomic imprinting & uniparental disomy: 
UPD is inheritance of both homologs of a chromosome from a 
single parent. 
Several autosomal chromosomes and X –chromosomes have been 
implicated with UPD and are associated with IUGR. 
Maternal UPD of chromosome 16 is most commonly associated 
with IUGR. Abnormal imprinting results in abnormal phenotypes 
including fetal growth restriction and dysmorphic features. In praderwilli 
syndrome loss of function of imprinted genes on the paternal allele in 15q 
11-13 leads to growth restriction in utero and associated with other 
developmental problems. 
Maternal Uniparental disomy involving imprinted region in  
chromosome 7, clinically characterised by prenatal and postnatal growth 
deficits and dysmorphic features. 
3. Fetal malformations: 
A population based study conducted by CDC demonstrated>22% of 
infants with congenital malformations are growth restricted with relative 
risk  of 2.6 (Khoury, Erickson 1998)
22
. 
Multiple malformations associated with increased risk of IUGR and 
the frequency was increased from 20% in infants with two defects to 60% 
14 
 
in infants with 9 defects. The cardiac anomalies most commonly 
associated  with small for gestation are  Tetrology of Fallot, Endocardial 
cushion defects, Hypoplastic left heart, Pulmonary stenosis, Ventricular 
septal defect, not only heart disease, anencephaly and anterior abdominal 
wall defects also associated with growth restriction in the fetus. A single 
umbilical artery even in the absence of other malformation or aneuploidy 
may be associated with fetal growth restriction. 
4. Perinatal infections : 
5-10% of IUGR is attributable to viral or protozoan infection in utero. 
The viral infections most commonly associated with growth restriction 
are Rubella, Cytomegalovirus, Human immuno deficiency virus and 
Varicella zoster. The early infection which causes decrease in cell 
population may be the most frequently associated mechanism in growth 
restriction. 
Protozoal infections like Malaria and Toxoplasmosis also leads to 
growth restriction of the fetus. In malaria the adverse effects include 
maternal anemia, prematurity and growth restriction. 
Bacterial infection is usually not associated with growth restriction 
there is evidence suggest that subclinical infection and inflammation 
leading to chorioamnionitis may result in growth restriction. Offenbacher, 
Lieff et al (2001)
23
 suggest that maternal periodontal disease can lead to 
preterm and small for gestation births and it could be a modifiable 
etiology of IUGR. 
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5. Multiple gestation : 
In multiple gestation the maternal system has to provide optimum 
environment for individual fetus to sustain fetal growth. Individual 
fetuses in multiple pregnancy shows different growth profile than  
singleton pregnancy. Guenwald (1966)
24
 demonstrated the growth curves 
of singleton and twins were sameupto 30-32 weeks after which the 
growth of the twins lagged behind that of singleton. 
Small for gestational birth  noted in 20% of dichorionic fetuses and 
30% of the monochorionic fetuses. The aetiology for this is similar to that 
of singleton pregnancy and include hypertensive disorders,poor weight 
gain,lowprepregnancymass index. An  additional factor in multiple 
pregnancy is discordant growth before 30 weeks is associated with twin 
to twin transfusion syndrome and high risk of perinatal mortality. 
PLACENTAL FACTORS : 
Placenta being the lifeline between mother and the fetus has a critical role 
in IUGR. The role is however mediated by anatomic, vascular, 
chromosomal &morphological abnormality. 
Abnormal placentation, placenta previa, chorionic villitis, placental 
infarcts, haemorrhagicendovasculitis, placental haemangioma, 
chorioangiomas are some of the placental conditions associated with 
IUGR. 
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COMPLICATIONS OF IUGR: 
ANTENATAL : 
Antenatal and intrapartum hypoxia, acidosis are the  important and 
frequent complications of IUGR. According to Lin et al., (1980)
3
 the 
incidence of non reassuring fetal heart rate pattern in electronic fetal heart 
rate monitoring during labour is up  to 40%. 
STILL BIRTH: 
Marana found (1980)
4
 that 20% of all stillborns shows evidence of IUGR. 
Morrisen and Olsen (1985) found 26% of stillborn weighting <2.5 kgs is 
associated with IUGR. 
OLIGOHYDROMNIOS: 
Chamberlain et al (1984)
6
 showed that the incidence of IUGR with 
normal amniotic fluid volume was <5% but when oligohydromnios was 
present it is up to 40%. 
INTRAPARTUM COMPLICATIONS : 
The incidence  of intrapartum hypoxia and acidosis are higher in IUGR. 
The incidence of caesarean section is increased due to nonreassuring fetal 
heart rate pattern in electronic fetal heart rate monitoring. 
 
17 
 
EARLY NEONATAL COMPLICATIONS: 
Respiratory distress syndrome: main cause of mortality and morbidity in 
IUGR. 
Meconium aspiration syndrome is also a major cause of mortality and 
morbidity. 
Persistent fetal circulation due to perinatal hypoxia and acidosis. 
Intraventricular bleeding and periventricular leukomalacia are the most 
frequent neurological complications of preterm IUGR. 
Neonatal encephalopathy is an essential component of cerebral palsy 
secondary of fetal asphyxia. 
Hypoglycaemic episodes occur in 25% of term IUGR and 67 % of 
preterm IUGR. 
Hypocalcaemia can occur secondary to chronic hypoxia. 
Hyper viscosity leading to necrotizing enterocolitis, pulmonary infarcts, 
hyper bilirubinemia. 
Hypothermia due inadequate subcutaneous fat. 
LONG TERM PROGNOSIS: 
Postnatal growth: Hill (1978)
7
 showed that 30% of babies will remain 
below 30
th
 percentile for their age and only 10-20% will be above 50
th
 
percentile. 
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Cerebral Palsy : Follow –up studies showed that intelligence, 
motor skills, speech and reading abilities are affected in IUGR babies 
(Robertson et al., (1990) Kok et al (1998),)
9.
 
Several studies shows incidence of chronic hypertension, abnormal 
lipid profile, ischemic heart disease, type 2 diabetes are increased in later 
life. 
Salafia (1997)
31
 proposed that not a single but several 
histological&morphological changes of placenta resulted in IUGR. 
Though the contribution of placental changes remained controversial, it is 
accepted that IUGR was associated with fetal hypoxia resulting partially 
from alternation in growth &development of placental villi & their 
underlying vasculature (Benrische, Kaufman 1995)
32
. 
PLACENTAL VASCULAR DEVELOPMENT IN NORMAL AND 
IUGR PREGNANCY: 
Maldevelopment of uteroplacental & fetoplacental circulatory 
system has been shown to be associated with fetal growth compromise 
and pre eclampsia. 
In the maternal placental circulation, a subset of trophoblasts 
invades the spiral endometrial arteries & remodel them into widely 
dilated uteroplacental arteries. As a result, the uteroplacental flow 
impendence progressivly declined & the maternal blood flow through the 
intervillous space exponentially increases. 
19 
 
The changes in the uteroplacental arteries occur in 3 phases; 
Before trophoblastic invasion, the arteries from both within and 
outside the implantation site show several changes including dilatation, 
vacuolation of endothelial cells and disrupted smooth muscle cells in the 
tunica media. 
In the next phase, the interstitial trophoblasts surround the spiral arteries 
& induce  fibrinoid deposition & other changes in the arterial media. 
Finally, the trophoblasts invade the arteries & are transformed into 
immensely dilated conduits devoid of vasoactive capability. 
These changes are more in the centre of the placenta than  the periphery. 
FETOPLACENTAL ANGIOGENESIS & IUGR : 
Feto placental angiogenesis is a continuous process starting soon after the 
implantation and evolving through pregnancy in 3 phases; 
From post conception day 21 to 32, vasculogenesis occurs in which 
capillary networks  formed will provide foundation for subsequent 
fetoplacental vascular & villous growth; 
From 32
nd
 day to 24 wks of gestation, branching angiogenesis dominates 
leading to the formation of 10-16 generations of stem villi. 
20 
 
Beyond 24 wks, the expansion of the feto placental vascular system is 
mainly by non branching angiogenesis characterized by elongation of the 
vessels rather than by branching. 
According to Krebs & colleagues (1996)
25
 and Todros& colleagues 
(1996)
26
, abnormal development of villous tree has shown to be 
associated with early onset pre eclampsia & IUGR. 
PLACENTAL TRANSPORT MECHANISM & IUGR: 
The concept of placental insufficiency in IUGR is by deficient maternal 
to fetal nutrient transport. 
Invitro human placental experiments shows diminished activity & 
expression of placental transporters for essential amino acids & ions in 
IUGR pregnancies (Cetin 2003)
27
 
Deficiency in glucose transport mechanisms has been observed in 
preterm IUGR than  term IUGR placentas (Jansson, Yivar et al 2002)
28.
 
ASSESMENT OF PLACENTAL GROWTH: 
There are so many standard placental growth parameter used in older 
birth cohorts are still in use. 
1. Placental disk shape: Normal placenta is round to oval in 
shape.Naye (1992)
29
 concluded that irregular placental shape was 
associated with parent & sibling seizure disorder and adverse 
pregnancy outcome like preterm birth/ neurologic abnormality at 
7yrs. 
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2. Location of umbilical cord insert in from the edge of the 
placenta: Cord malposition may be due to abnormal growth of 
placenta towards one side or abnormal positioning of the embryo. 
Nayesanalysed that marginal cord insertion was associated with 
twinning & major fetal malformation & also with maternal 
acetonuria during 1
st
 trimester, Diabetes, IUGR. 
3. Placental disk diameter: It determines the maximum number of 
spiral arteries that are involved in uteroplacental unit. 
4. Disk thickness : Most of the placental growth in 3rd trimester is  by 
increase in placental thickness which reflects the extent of nutrient 
exchange surface of the placenta essential for the successful and 
adequate fetal growth. Increased disk thickness decrease the 
placental efficiency and so abnormally thick placenta is also 
associated with adverse pregnancy outcome (Radio, Ghazzi et al 
2004)
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5. Feto placental weight ratio. 
Only few workers  performed histomorphometric studies of the 
placenta associated with IUGR. Aherne&Dunnill (1996)
33
 studied 
quantitative aspects of placental structure. They observed the IUGR 
infants born at term had placenta with reduced mean volume (350 ml). 
The mean values for volume proportions of chorionic villi was not 
differ from control. 
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In early 80s Geiresson et al
34
 studied the use of measuring 
placental volumes in normal & abnormal pregnancies. 
In 1984 the first fetal  placental volumes  studied by USG were 
constructed by Brinkley at el. After the development of 3 dimensional 
USG imaging assisted by computer technology it is possible to measure 
and calculate fetal & placental volume quickly & accurately ,measuring 
and monitoring the fetal and placental volume at different gestational 
ages may improve our understanding about pathophysiological 
mechanisms of fetal & placental growth. Fetal and placental volumes can 
be used in screening of fetuses with chromosomal anomalies ,IUGR , 
preeclampsia. Some reports in literatures says that increase in placental 
volume preceding preeclampsia & decrease in placental volume 
preceding IUGR & decrease in fetal volume in fetuses with chromosomal 
anomaly. 
Wallance et al (2004) concluded  the small size of the placenta per 
se rather than alternation in the nutrient metabolism or transferring 
capacity has a major limitation to fetal growth. 
Thame& colleagues (2005)
35
 have  shown  the effects of maternal 
anthropometry on birth weight is likely to be mediated by effects of 
maternal anthropometry on placental volume. These effects operate in 
pregnancy and alter both the absolute placental volume at 14 wks and rate 
of growth of placenta between 17 & 20 wks. 
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Clap & colleagues (2004)
36
 identified a  relationship among the 
rate of increase in individual maternal IGF 1 levels after 16 wks, 
placental mass & neonatal fat mass. 
Laviola, Perrini et al (2005)
37
 showed an abnormal IGF signaling 
was linked to human IUGR. 
Lepereq& colleagues (2003)
39
 showed Leptin  contributes to this complex 
communication between mother, fetus & placenta may be an early 
Response Element to placenta dysfunction. 
I.Cetin G, Alvino (2009)
40
 showed that IUGR has been linked with 
a specific placental phenotype associated with defects in placental 
transport function that lead to fetal undernutrition. Both placental 
transport and metabolism may be affected and modifies the nutritional 
supply to the fetus. In pregnancy, nutrient concentration can be measured 
at the time of delivery or at the time of cordocentesis. In IUGR  the 
placental supply of aminoacid is significantly reduced independently 
from the severity of growth restriction and from the presence of hypoxia. 
Moreover maternal , fetal gradient of glucose are increased in severe 
IUGR. This summarizes the current knowledge about placental 
metabolism and transport in IUGR pregnancies and the relationship with  
severity of the disease. 
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I Cetin, J M, Foidart, M Moazzo (2004)
41
 
IUGR are associated with increased perinatal mortality and morbidity  as 
well as cardiovascular disease and  glucose intolerance in adult life. A 
number of genetic , metabolic, vascular, coagulative, autoimmune as well 
as  infections can influence fetal growth by damaging the placenta. Strict 
definition of IUGR and its severity are needed so as to eventually 
distinguish among different phenotypes such as gestational age at onset, 
degree of growth restriction and presence of hypoxia. New existing 
findings on the genomic imprinting defects are potentially associated with 
IUGR. 
Marcus Rijken, Williams E Moroski, SupornKiricharo (2012)
42
 
Studied the effect of malaria on placental volume measured using 3 
dimensional ultrasound. Malarial parasites and histopathological changes 
in placenta is associated with reduction in birth weight principally due to 
IUGR. They studied the feasibility of measuring  early pregnancy volume 
by 3 dimensional ultrasound in malaria endemic area. They found that 
small placental volume in second trimester is an indicator of IUGR and 
placental insufficiency. 
Imdal, Aamer, Yakob, Mohammad Yawar (2011)
43
 
Studied relation between stillbirth and IUGR. Early detection and 
management of IUGR  leads to reduced  morbidity and mortality. They 
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reviewed the effectiveness of fetal movement count and Doppler for 
detection and surveillance of high risk pregnancy and the effect of it in 
the prevention of stillbirth. They also reviewed the effect of Body mass 
index screening, symphysio fundal height, target ultrasound in detection 
and triage of IUGR in the community. Finally they concluded that there is 
insufficient evidence to  recommend in favour or against fetal movement 
count for routine use of testing fetal wellbeing. Arterial Doppler analysis 
and appropriate intervention is associated with 29% reduction in perinatal 
mortality (95% CI 2-48). Expert opinion suggests that detection and 
management of IUGR with  help of maternal Body mass index, 
symphysio fundal height, targeted ultrasound could be effective in 
reducing IUGR related stillbirth by 20%. 
Hata T, Tanaka H, Noguchi J, Hata K (2011)
44
 
Studied the effectiveness of conventional 2 dimensional ultrasound in 
evaluation of placenta in pregnancy. This 2 dimensional ultrasound 
evaluation includes morphology, anatomy, location implantation, 
anomaly, size, power and pulsed Doppler sonographic assessment of 
placenta. The introduction of 3 dimensional ultrasonography would 
facilitate  novel assessment of the placenta such as surface rendered 
imaging and volume assessment, the novel technique may assist in the 
evaluation of fetoplacental function and offer potential advantages than 
conventional 2 dimensional sonographic measurement. 
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Hafner, philippschuchter (2002)
 45
 
Suggested that the prognostic influence could be shown for placental 
volume, gestational age at the time of measurement and maternal weight 
at the time of 1
st
 visit. 
Ferrazi, Bulfamante, Mezzopane (1998)
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Stated that the presence of abnormal Doppler velocimetry of the uterine 
arteries in pregnancies with IUGR may be in fact an important indicator 
of hypoxic or ischemic placental lesions. This abnormal velocimetry is 
independent of the maternal blood pressure status. 
Noguchi J, Tanaka H, Hata T (2009)
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Investigated placental vascular sonobiopsy using 3 dimensional 
ultrasound in normal and IUGR pregnancies. Placental vascular 
sonobiopsy using 3 dimensional power Doppler ultrasound with VOCAL  
imaging was performed in 208 normal fetuses between 12-40 weeks and 
13 pregnancies with IUGR between 22-39 weeks gestation. 3 dimensional 
power Doppler indices related to placental vascularisation were 
calculated. They found that the placental vascular sonography may 
provide new information in the assessment of placental vascularisation in 
normal and IUGR pregnancies and placental perfusion is reduced in 
IUGR compared to normal. 
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Jang, DongGyu, Jo, Yun Sung, Lee (2011)
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Evaluated the perinatal outcome and maternal characteristics in 
IUGR with absent or reversal of end diastolic flow (AEDV) independent 
of oligohydromnios, gestational age, and maternal factors. They 
compared 57 normal and 19 patients with Absent end diastolic flow. They 
found that the gestational age was lower in AEDV group when compared 
to normal group. The birth weight and platelet count were lower in 
AEDV group and serum SGOT, non reassuring CTG were higher 
independent of gestational age. Perinatal outcome such as Apgar at 1 
minute <4 use of ventilator, admission to NICU, respiratory disease, 
neurological disease, neonatal sepsis, anaemia, thrombocytopenia, and 
neonatal mortality were statistically less favourable in AEDV group. 
Hafner et la (1998) revealed the measurement of placental volume 
between 16 & 23 wks of gestation has a sensitivity of 53.5% in the 
prediction of IUGR and neonatal birth weight below 10
th
 percentile. 
HLAFNER, PHILIPP, SCHUCHTER (2002)
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Conducted prospective study in 382 women with singleton uncomplicated 
pregnancies at 16-23 wksinorder to investigative the value of 2
nd
 trimester 
3- dimensional sonographic placental volume measurement to predict 
infants who are <10
th
 percentile for birth weight. They inferred that 
placental volume estimation in predicting IUGR had 82.5% sensitivity & 
52.5% specificity and prognostic influence could be shown for placental 
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volume (p<0.0001), gestational age at the time of measurements (p= 
0.0002) & maternal weight at the time of registration (p=0.0025). they 
concluded that 3- dimensional sonographic measurement of placental 
volume alone is not a satisfactory technique of predicting IUGR. 
GIUSEPPE, RIZZO, ALESSANDRA CAPPONI (2008)
50
 
Compared the efficacy of uterine artery Doppler velocimetry & 3- 
dimensional sonographic measurement of placental volume, alone or in 
combination at 11-14 wks of gestation as a predictor for development of 
pre eclampsia. It was a prospective study involving 348 women who were 
subjected for a routine prenatal ultrasonogram at 11-14 wks& the mean 
pulsatility indexof uterine artery was calculated and, placental volume 
was measured using 3- dimensional sonogram. The outcome considered 
were development of preeclampsia & pre eclampsia requiring delivery < 
32 wks. On observation they found  the placental volume was 
significantly lower in women who developed pre eclampsia later ( 
p<0.003). There was no relationship between placental volume  & mean 
uterine artery pulsatility index (p= 0.327). Both showed similar 
sensitivities in predicting pre eclampsia (60% vs 66 % ) & pre eclampia 
requiring delivery before 32 wks (66.7% vs 67%). The combination of 
both gave better results with sensitivity of 68.7 % in predicting 
preeclampsia & 83.3 % for requiring delivery < 32 wks. So they 
concluded that the combination of abnormal uterine artery Doppler & low 
placental volume at 11-14 wks had better results than done alone. 
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CHRISTIANE KREBS, LENA.M MACERA, RUDOLF LEISSSER 
(1998)
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They studied the structure of placental terminal villi & their 
capillaries in pregnancies complicated by IUGR with absent end diastolic 
flow in umbilical artery. 10 placental specimens were taken from IUGR 
pregnancies and from well matched normal pregnancies as control. The 
structure and dimensions of 20 terminal capillary loops were determined 
by electron microscopic examination & their appearance were correlated 
with peripheral villi. The result observed was in the IUGR cases the 
capillary loops were sparse in number, & significantly longer than control 
cases (218 vs 137 um). They also had fewer branches (4/loops vs 6/loops, 
p< 0.06) and the majority of the loops were uncoiled (79% vs 18%, p 
<0.06). From this they concluded that the terminal villous compartment 
of the placenta appeared to be maldeveloped in IUGR with absent end 
diastolic flow in umbilical artery before delivery. These findings were 
consistent with increased fetoplacental vascular impedance at capillary 
level & it might be account for the impaired gas and nutrient transfer 
across the placenta. 
THAME OSMONDE, WIKS
52
 
They investigated the ability of 2
nd
 trimester placental volume 
measurement by ultrasonogram in the prediction of birth weight of the 
fetus. They selected 512 women and measured fetal anthropometry & 
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placental volume serially at 14, 17, 20 wks. The outcome was focused on 
birth weight, anthropometric measurement  at birth, & placental weight. 
The result of the study was the placental volume positively correlated 
with all birth measurements. The Head circumference was the strongest 
predictor of birth weight at 14 wks (p= 0.014) & 17 wks (p=0.012), but at 
20 wks abdominal circumference was the strongest predictor. Finally they 
have concluded that low birth weight was often preceded by small 
placental volume in 2
nd
 trimester. Hence placental volume might be  the 
reliable predictor of birth weight than fetal anthropometry & it may be 
useful in early identification of fetus at risk. 
HUMBERTO AZPURUA, EDMUND F.FUNAI, LUISA 
M.CORALLUZI
53
 
Conducted a prospective study involving 29 3
rd
 trimester pregnancies & 
estimated placental volume with 2 dimensional ultrasonogram before 48 
hrs of delivery. After delivery also they calculated placental volume, and 
comparedthese two. They found significant correlation between the 
estimated placental volume and actual placental volume after birth. They 
concluded that placental volume can be accurately predicted by 2 
dimensional ultrasound with volumetric calculation. 
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JIE DUAN ANNE-CLAIRE CHABOT-LECOANET ESTELLE 
PERDRIOLLE-GALET 
Evaluation of utero-placental vascular modification during pregnancy 
using usg recently became possible. Since 2004, it is possible to quantify 
placental and myometrium vascularisation by 3D power Doppler 
angiography (3DPD).This method allows to study the vascularisation of 
organ of interest. Quantification is based on calculation of the ratios of 
voxels with Doppler signals to the intensity of Doppler signals in the 
voxels. Three typical indices of a volume of interest were calculated by 
this method: the vascularisation index (VI), flow index (FI) and 
vascularisation-FI (VFI). The feasibility and reproducibility of Doppler 
signal quantification by calculating VI, FI and VFI were found to be 
satisfactory in vitro and in vivo 
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MATERIALS AND METHODS 
This  prospective analytical study was conducted at government 
RSRM lying in hospital, Chennai coming under the stanley medical 
college, Chennai from 2017 to 2018 Ethical committee clearance was 
obtained to undergo the study. 
The patients referred as IUGR beyond 32wks up on term were 
carefully analysed. The inclusion criteria used were, 
1. With singleton pregnancy 
2. Well known gestational age 
3. Without any maternal medical complications, 
4. With first trimester ultrasound for confirming the gestational age 
and second trimester ultrasound to rule out fetal anomaly and 
serial ultrasound to see the interval growth. 
These patients were screened with clinical method of measuring fundal 
height. If it was lagging behind 4 weeks for their gestational age, then 
they were subjected to ultrasound and fetal biometry and estimated fetal 
weight were measured. 
Estimated fetal weight of < 10
th
 percentile for their gestational age with 
ultrasound were selected for the study after getting informed consent. 
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Exclusion criteria : 
Patients with multiple pregnancy, abnormal placentation, fetal 
malformation were excluded. 
Patients with severe oligohydramnios in which there was difficulty in 
localizing the placenta were excluded from this study. 
And also in patients in whom there was difficulty in localizing as well as 
measuring the placenta due to fundal or lateral wall insertion were 
executed. 
Detailed history was taken & patients with hypertension, diabetes, other 
medical disorders were excluded to avoid errors in monitoring the 
perinatal outcome. 
Examination of the selected patients: 
Name, age, unit, Registration Number, Address, Socioeconomic 
Status, Occupation were noted. 
In multigravidas, detailed history of previous pregnancies 
including duration of pregnancy, mode of delivery, birth weight of the 
baby, perinatal outcome and pregnancy complications like gestational 
hypertension, pre eclampsia, gestational diabetes mellitus were elicited. 
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Details of present pregnancy including last menstrual period, 1
st
 
trimester ultrasonogram, any h/o bleeding episodes, /h/o fever episodes in 
the first trimester were noted. 
Details about second trimester including the targeted ultrasound to 
rule out fetal anomaly, h/o iron and folicacid intake, immunization, and 
history suggestive of preeclampsia were recorded. 
Regarding third trimester, the follow-up ultrasound to assess the 
interval growth, history suggestive of pre eclampsia were recorded. 
Detailed clinical examination of the patient was done & height, 
weight, BMI, blood pressure were noted. Routine laboratory 
investigations also done. Obstetric examination was done & a lag in 
fundal height of more than 4 weeks taken into consideration. Those 
patients selected for the study were subjected to ultrasound examination. 
Ultrasound examination: 
The machine used for 2 Dimensional ultrasound examination was GE 
with a 5 MHz curvilinear probe. 
Fetal parameter like BPD, HC, AC, FL were measured as described 
below, Estimated fetal weight was calculated with the above 
measurements by ultrasound and confirmed whether it was <10
th
 
percentile. 
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Amniotic fluid index was also done. Placental localization was done. 
The probe was adjusted for seeing both edges of the placenta in the same 
image and the image was frozen. With this placental width and height 
were measured. Then placental thickness was measured possibly at the 
level of cord insertion. 
Measurement of placental volume was done by using the convex- 
convave shall formula. 
V=   t/6 X (4H(W-T) + W(W-4T)+4T2); 
H= PLACENTAL HEIGHT, 
W= PLACENTAL WIDTH. 
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Diagrammatic representation of measurement of placental volume 
USG measurement of placental volume 
T – Thickness 
W – Width 
H- Height 
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Doppler study was done on the umbilical artery, middle cerebral 
artery as described below. Umbilical cord was located in the pool of 
Amniotic fluid and the middle cerebral artery was localized in the 
transverse section of the fetal skull at the level of thalamus in the sylvian 
fissure. The Doppler signals appropriate for the vessels were identified. 
The signals were recorded for a minimum of 5-8 cycles with blood flow 
velocity waveforms of equals shape and amplitude and of satisfactory 
quality were obtained. The image was frozen and the measurements of RI 
( RESISTANCE INDEX) was taken Cerebroplacental ratio was 
calculatedfrom the RI of umbilical and middle cerebral artery (RI of 
MAC /RI of UA). Doppler was considered abnormal when the (RI value 
above 95 th percentile for the gestational age in umbilical and middle 
cerebral artery or there was absent/ reversal of diastolic flow in umbilical 
artery or CPR <1. 
MEASUREMENT OF PLACENTAL BED VASCULARITY 
For the estimation of number of vessels in the placental regions we 
used the VI to count the number of colour voxels in a particular region of 
interest in comparision to its grey voxels which gives the percentage of 
colour to grey voxels.It is known that VI is significantly influenced by 
power doppler settings like gain,signalpower,pulse repetition 
frequency.To measure the VI in the placental bed a power doppler colour 
box was placed over the entire placenta and the adjoining myometrium. 
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Inorder to calculate placental bed vascularity(PBVI),placentas were 
rotated in a horizontal position in both A and B plane.using an inbuilt 
programm for volume measurements ,the border between placenta and 
deciduomyometrium was carefully traced in a A-plane by caliper.The 
caliper was then moved into deciduomyometrium. The thickness of 
deciduomyometrium or placental bed measured,however, as it can differ 
from millimeters to centimeters.To solve this problem,placental bed was 
measured from its direct attachment at the placenta upto a thickness of 1 
cm,which is made possibly by using the display measure ,given by the 
machine.only if the placental thickness is less than 1 cm this smaller 
value taken for measurement.The placenta was then rotated by 30 degree 
in a horizontal plane and tracing was repeated.As the angle size of the 
horizontal rotation is 30 degree it takes six cuts to completely define the 
placental borders.After this machine calculates the VI automatically. 
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USG Measurement of placental bed vascularity 
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Patients with normal fetal growth were selected as control. The 
inclusion criteria for selection were same that of IUGR to avoid errors in 
comparision. Patients with singleton pregnancy, well known gestational 
age, appropriate interval growth in previous serial ultrasound, without 
any systemic medical disorder were included in the study. 
Patients with multiple pregnancy, fetal anomaly, or abnormal 
placentation and with maternal complications were excluded. 
In this group also detailed history was elicited. Details of this 
pregnancy like last menstrual period, 1
st
 trimester ultrasonogram, 2
nd
 
trimester anomaly scan,3
rd
 trimester interval growth were noted. In 
multigravidas, history regarding pervious pregnancy & its outcome and 
any pregnancy complications were recorded. 
Detailed clinical examination was done. Ultrasonography was also 
done & the fetal biometry, AFI, placental localisation, placental volume 
were measured in the same way. Here also patients with difficulty in 
localizing the placenta were excluded from this study. 
All cases were observed till delivery. patients were followed up 
with fetal surveillance with daily fetal movement count, modified 
biophysical profile, repeat ultrasonogram if needed to observe the interval 
growth. Once decided for termination, Placental volume by 2 dimensional 
ultrasound was repeated if done 48 hrs before delivery. 
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Mode of delivery was noted. In case of vaginal delivery, careful 
intrapartum monitoring done. If decided for caesarean section, the 
indication was noted. 
At delivery, baby was looked for APGAR score at 1 and 5 minutes. 
Colour of liquor, meconium staining of umbilical cord were noted. Birth 
weight of the baby was taken. 
After delivery of the placenta the cord was immediately tied close to the 
insertion to prevent the loss of blood from the placenta. The remaining 
cord was cut. Membranes were trimmed from the edge. The placenta was 
kept on the flat surface and maximum, minimal width were measured 
with an inch tape. Maximum height was measured. With the these 
measurements, placental volume was calculated by the following 
formula; 
V=    ABH 
A= Major width, 
B= Minor width, 
H= Height. 
The placental volume measured before delivery was compared with 
that of after delivery. 
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METHODS OF ULTRASOUND AND DOPPLER 
MEASUREMENT 
BIPARIETAL DIAMETER 
Biparietal diameter helps to determine the gestational age and type 
of IUGR. But using BPD alone for diagnosing IUGR has poor sensitivity. 
According to Campbell S, Deuhurst (1971)
54
  when BPD is below 5
th
 
percentile, 82% of birth weight are below 10
th
 percentile. BPD may also 
give false positive result due to alteration in shape of the head as in 
brachycephaly or dolichocephaly. 
It is a two dimensional measurement. Any plane of section through 
360 degree are that passes through the thalami and 3
rd
 ventricle is 
acceptable for measuring BPD & it is measured form outer edge of the 
skull of the proximal surface to the inner edge of the fetal skull on the 
proximal surface to the inner edge of skull on the distal surface. 
HEAD CIRCUMFERENCE : 
HC is better than BPD in predicting IUGR as it is not subjected to 
variability. 
It is measured at the same level of BPD using the method of expanding 
ellipse. 
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FEMUR LENGTH: 
FL is an excellent parameter to calculate gestational age, as it is not 
significantly affected by IUGR. 
It is a single dimensional management. The transducer is aligned to 
the long axis of the diaphysis of the bone to obtain a proper plan of 
section. Only the ossified portions of the diaphysis and the metaphysis are 
measured. Proper alignment of the transducer to the long axis of the bone 
is ensured by demonstrating that both the femoral head or greater 
trochanter and the femoral condyle are simultaneously in the plane of 
section. 
ABDOMINAL CIRCUMFERENCE: 
AC has highest sensitivity and greatest negative predictive value in 
diagnosis of IUGR. AC value < 10
th
 percentile for gestational ag has 
negative predictive value of 93% and positive predictive value of 67%. 
AC of >25
th
 Percentile has negative predictive value of >  95%. 
It is three dimensional measurement. The AC is measured at a position 
where the transverse of the liver is greatest. It is determined 
sonographically  as the  position where the right and left portal veins are 
continuous with one another. 
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ESTIMATED FETAL WEIGHT: 
Determination of  estimated fetal weight by ultrasonogram requires 
accurate measurement of BPD, HC, AC, FL. Accirdubgti Ott, (1997)
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fetal weight estimation has sensitivity of 89% specificity of 88%, positive 
predictive value of 45% negative predictive value of 99% in detection of 
IUGR. 
According to Chervenac et al (1984)
56
 when EFW is below 
0.5%confidence limit the probability of IUGR is 82% and if it is between 
0.5-20% confidence limit, the probability is 24%. 
PARAMETER BPD AC FL EFW 
SENSITIVITY 75% 95% 45% 65% 
SPECIFICITY 70% 60% 97% 96% 
POSITIVE 
PREDICTIVE 
VALUE 
21% 21% 64% 65% 
NEGATIVE 
PREDICTIVE 
VALUE 
96% 99% 94% 96% 
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DOPPLER STUDIES : 
The Doppler principle was first described by Johann Christian 
Doppler in 1842. The use of Doppler in the evaluation of fetal circulation 
has been adequately assessed in randomized control  trials and it has been 
found to be useful. The use of Doppler in obstetrics requires adequate 
understanding of feto-placental and materno –placental circulation. The 
Doppler study of arterial and venous system of the feto-placental unit has 
been found to be useful. 
- in complementing other methods of fetal surveillance such as 
NST, BPP in more precisely determining the degree of fetal 
compromise. 
- as a follow up test when other tests of fetal well being give 
ambiguous results, 
- in identifying high risk of placental insufficiency and fetal 
complications, 
- in evaluating the presence and severity of fetal anemia. 
There are several methods of analyzing Doppler wave form to 
provide a quantitative index of vascular resistance namely S/D Ratio, PI 
(Pulsatility Index) , RI (Resistance Index). The objective of these indices 
in to obtain a numerical value from the wave form, so that we can asses 
the resistance to the blood flow of the vessel being studied. 
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S/D RATIO= Mean systolic velocity/ Mean diastolic Velocity. 
PI = systolic velocity- diastolic velocity /mean velocity. 
RI = systolic velocity- diastolic velocity / systolic velocity. 
In this study we have taken the RI as an index of vascular 
impedance. 
Umbilical artery 
The umbilical artery Doppler provides the index of resistance to 
blood flow on the fetal side of the placenta. 
A loop of umbilical cord midway between the fetal and placental 
insertion was located. Because measurement close to the placental 
insertion shows high resistance flow and close to the fetal insertion shows 
high resistance flow and close to the fetal insertion shows low resistance. 
That segment of umbilical cord is elongated so that 2 umbilical artery and 
I umbilical vein could be distinguished. Angle of insonation was adjusted 
to <60 degrees. An optimum Doppler signal was obtained and the 
Resistance index was measured. 
GESTATIONAL AGE RESISTANCE INDEX 
34 WKS 0.62-0.74 
35 WKS 0.61-0.73 
36 WKS 0.59-0.72 
37 WKS 058-0.71 
38 WKS 0.57-0.70 
39 WKS 0.56-0.69 
40 WKS 0.55-0.68 
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The resistance to the blood flow through the umbilical artery 
decreases as the gestational age advances. Whenever there is placental 
insufficiency, there are certain adaptive changes that takes place in the 
fetal circulation which can be observed in Doppler waveforms. 
The sequence of events are as follows: 
1. Increased umbilical artery resistance without centralization of flow. 
2. Increased umbilical artery resistance with centralization of flow. 
3. Absent diastolic flow in the umbilical artery. 
4. Reversed diastolic flow in the umbilical artery. 
5. Alteration in venous circulation. 
The initial phases indicates the fetal compensatory mechanisms to 
increased placental vascular resistance. When the diastolic flow in the 
umbilical artery becomes absent or reversed, it indicates that the fetal 
compensatory mechanisms exhausted and hypoxia and acidosis has set in. 
Alternation in venous circulation indicates the fetus is in hemodynamic 
decompensation and at risk of imminent death. 
Middle cerebral artery 
When the placental resistance increased to a certain threshold, the 
fetus develops a compensatory response by increasing blood flow to the 
vital organs like  Brain & Heart, and decreases blood flow to peripheral 
organs. This is evidenced in Doppler study as decrease in resistance of 
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middle cerebral artery blood flow which originally has high resistance 
flow. This centralization indicates the fetal compensatory mechanism to 
the increased resistance to the blood flow. 
Section of fetal skull for BPD measurement was obtained and then the 
transducer was angulated caudally till the middle cerebral artery courses 
along the sphenoid wings. The volume size and angle of insonation were 
adjusted after placing the cursor over the artery and appropriate signals 
were obtained and the RI was measured. 
GESTATIONAL AGE RESISTANCE INDEX OF MCA 
34 WKS 0.73-0.86 
35 WKS 0.72-0.85 
36 WKS 0.70-0.83 
37 WKS 0.68-0.81 
38 WKS 0.66-0.80 
39 WKS 0.63-0.78 
40 WKS 0.61-0.76 
 
The MCA resistance index also decreases with gestational age but 
remains higher than that or umbilical artery. 
CEREBRO PLACENTAL RATIO: 
It is the ratio between RI of MCA & RI  of UA. According to Aras 
(1994)
57
, CPR <1 identifies the fetuses at risk of IUGR and poor perinatal 
outcome. The predictive value of the CPR loses after 34 weeks (Bahado 
Singh et al 1999). 
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OBSERVATION AND RESULTS 
This prospective analytical study was conducted with 100 normal 
pregnancy  as control group and 100 IUGR pregnancy as study group. 
The following observations were made. 
1. GESTATIONAL AGE: 
In our study IUGR above 32 weeks of gestation were taken . The 
number of patients in normal pregnancy were selected according to this 
gestational age for better comparison. The number of patients presented 
in both group were, 
GESTATIONAL AGE IUGR 
NORMAL 
PREGNANCY 
32 -34 WKS 2 8 
34-36 WKS 43 45 
36-38 WKS 40 40 
38-40 WKS 15 7 
 
According to the above date, the commonest gestational age group 
presented was 34-36 weeks . 
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2 .MATERNAL AGE 
In IUGR group,76 patients presented in the group of 25 to 36 years 
MATERNAL  
AGE(YEARS) 
IUGR NORMAL 
PREGNANCY 
18-24 24 22 
25-30 28 36 
31-36 48 41 
>36 0 1 
 
3. PARITY 
In our study both primigravidas and multigravidas presented 
equally and patients in normal group also selected like that. 
 
4. PLACENTAL VOLUME 
The average placental volume observed according to gestational 
age as follows 
GESTATIONAL   AGE IUGR 
NORMAL 
PREGNANCY 
32-34 WKS 325 490 
35-37 WKS 492 594 
38-40 WKS 586 680 
PARITY IUGR 
NORMAL 
PREGNANCY 
PRIMI 37 39 
MULTI 63 61 
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5. IUGRDOPPLER ANALYSIS 
All patients in IUGR group were subjected to doppler study. The 
findings were, 
CPR <1         48 
CPR>1           52 
6. PBVI 
The placental bed vascularity between normal and IUGR is as follows 
GA PREGNANCY MEAN 
33-34 WKS Normal 31.2 
IUGR 20.79 
34-35 WKS Normal 30.25 
IUGR 22.69 
35-36 WKS Normal 31.13 
IUGR 24.49 
36-37 WKS Normal 30.43 
IUGR 22.59 
37-38 WKS 
 
Normal 30.39 
IUGR 22.22 
38-39 WKS Normal 30.34 
IUGR 24.2 
39-40 WKS Normal 31.1 
IUGR 27.3 
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7. MODE OF DELIVERY 
 
All patients were observed till delivery.mode of termination noted. 
 
MODE OF DELIVERY NO.OF PATIENT 
VAGINAL 26 
LSCS 74 
 
 
8. BIRTH WEIGHT OF THE BABY 
Birth weight of the baby in IUGR group noted 
BIRTH WEIGHT NO.OF BABIES 
<1KG 2 
1-1.5 20 
1.6 TO 2 49 
2.1 TO 2.5 29 
 
9. OUTCOME OF THE BABY 
 
Among 100 babies 53 babies had good outcome without any 
perinatal mortality or morbidity.The remaining 47 babies had adverse 
outcome. 
OUTCOME OF THE BABY NO.OF BABIES 
GOOD OUTCOME 53 
IUD 2 
NND 9 
LOW APGAR 24 
MSAF 12 
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DISCUSSION 
 The datas obtained from this study were analysed by statistical 
methods appropriate for the variables compared. Comparison of variables 
between IUGR and NORMAL pregnancy groups: 
1. GESTATIONAL AGE 
 In this study gestational age above 32 weeks were taken very 
preterm IUGR were excluded from the study to  avoid errors in assessing 
perinatal outcome.Among 100 patients with IUGR,85 patients were 
between 32 to 37 weeks.patients between 38 to 40 weeks were 
15only.This shows that incidence of early IUGR is more common than 
that of late IUGR. 
GESTATIONAL AGE DISTRIBUTION 
 
This showed maximum number of IUGR presented in this study 
was between 34 to 36 weeks. 
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2. MATERNAL AGE 
 In patients with IUGR,76 patients were in the age group of 25 to 
36years.It shows there is positive association with increasing maternal 
age and IUGR.the most common age group presented were 31 to 36 
years. 
Maternal Age Distribution 
 
 
This shows there is positive correlation between advancing 
maternal age and IUGR. This denotes that advancing maternal age may 
be an independent risk factor for IUGR. 
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3. COMPARISON OF PARITY: 
In our study both primi and multi were presented equally. 
Taj mohammed, Asmat are (200) concluded that primiparity was 
also a significant risk factor for IUGR. Similar findings were reports by 
Fikree et al & Thompson et al. 
Parity 
 
Patternson RM, Gibbs, Woods (1986) reported, prevalence of 
recurrent IUGR is significantly related to severity of growth restriction in 
previous pregnancy & severe placental insufficiency had 10% recurrence 
risk. 
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In our study group of IUGR, among  the multigravidas 11 patients 
had h/ o previous low birth weight babies. Among the 11 babies 2 were  
died in the neonatal period due to sepsis. 
The rest of the multigravidas had no details regarding previous 
pregnancy. 
PARITY H/O IUGR 
GOOD 
OUTCOME 
NND 
1 LIVE CHILD 9 8 1 
>1 LIVE CHILD - - - 
NO LIVE CHILD 2 - 1 
 
4. COMPARISON OF PLACENTAL VOLUME: 
De, paula CF, ruano R, Campos JA (2008) developed nomograms for 
placental volume in normal pregnancies from 12-40 weeks by measuring 
it with 3 dimensional ultrasonography. The placental volume measured in  
our study was compared with that. 
Gestational Age 
PV 10
th
 
Percentile (cm
3
) 
PV 50
th
 
Percentile (cm
3
) 
PV 90
th
 
Percentile (cm
3
) 
32Wks 326 346 384 
33Wks 184 315 494 
34Wks 160 327 486 
35Wks 186 350 584 
36Wks 320 474 590 
37Wks 198 520 586 
38 Wks 200 577 640 
39Wks 540 644 675 
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Based on the above nomograms, the Placental volume was graded in 
to 3 types as follows 
1. Grade -1: The placental volume falls above 50th percentile but 
below 90
th
 percentile. 
2. Grade -2: The placental volume falls below 50th percentile but 
above 10
th
 percentile. 
3. Grade-3 : There  is severe reduction in placental volume & falls 
below 10
th
 percentile. 
The placental volume according to the gestational age further 
divided into 3 grades and compared. 
GESTATIONAL 
AGE 
GRADE 1 GRADE 2 GRADE 3 TOTAL 
34-36 WKS 15 26 6 47 
36-37 WKS 12 8 2 22 
37-38 WKS 20 1 2 23 
38-40 WKS 7- - 1 8 
 
This shows the more earlier the gestational  age, severe reduction 
in the placental volume. Near term there is only mild reduction in the 
placental volume. 
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PLACENTAL VOLUME ACCORDING TO GESTATIONAL AGE 
 
 Comparing the grading of the placental volume, most of the 
patients had grade1 placental volume (n=54) where the placental volume 
was above 50
th
 percentile. In 32-37 weeks, most of the patients has grade 
2, grade 3 placental volume than grade 1 placental volume. Whereas in 
38-40weeks of gestation, most of the patients had grade 1 placental 
volume. This indicates in the early onset IUGR, placental insufficiency is 
more when compared to late onset IUGR. 
 The average placental volume observed in normal pregnancy. In 
normal pregnancies for all gestational age the placental volume was 
around 90
th
 percentile. 
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PLACENTAL VOLUME IN NORMAL PREGNANCY 
 
 
When comparing the average placental volume of normal & IUGR 
pregnancy, the following was observed. 
GESTATIONAL AGE IUGR 
NORMAL 
PREGNANCY 
32-34 WKS 325CM
3
 490 CM
3
 
35-37 WKS 492 CM
3
 594 CM
3
 
38-40WKS 586 CM
3
 680CM
3
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PLACENTAL VOLUME ACCORDING TO GESTATIONAL AGE 
IN NORMAL AND IUGR 
 
 This chart shows there is significant reduction in placental 
volume in IUGR group when compared with normal pregnancy in all 
gestational age group. The reduction in placental volume is more 
significant in the early gestational group. As the gestational age advances 
the difference in placental volume between IUGR and normal pregnancy 
becomes less significant. 
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 On statistical analysis the following was observed. 
STUDY 
GROUP 
MEAN 
PLACENTAL 
VOLUME 
STANDARD 
DEVIATION 
SIGNIFICANCE 
IUGR 400.91 38.177 0.001 
NORMAL 
PREGNANCY 
582.82 124.854 0.001 
 
P=0.001** Highly significant. (leavenes T-Test) 
When comparing the average placental volume of all gestational age 
group in IUGR with that of normal group, there is statistically significant 
reduction is noted. 
With the above findings, we can conclude that in IUGR pregnancies 
without any identifiable aetiology, the placental insufficiency of unknown 
cause plays a major role. 
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2. COMPARISON OF PLACENTAL GRADING WITH 
MATERNAL AGE: 
 On comparing the placental grading with maternal age the 
following was observed. 
MATERNAL 
AGE 
GRADE 1 GRADE 2 GRADE 3 TOTAL 
18-22 YRS - 1 10 11 
23-27 YRS 7 8 1 15 
28-31 YRS 13 12 - 25 
32-36 YRS 30 10 1 41 
>36 YRS 4 4 - 8 
 
PLACENTAL GRADING AND MATERNAL AGE 
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This diagram shows the comparison of placental grading with maternal 
age.  Here, more severe placental volume reduction was noticed in 
younger age group. With advancing maternal age only mild reduction in 
placental volume  was observed. In the commonest age group presented 
in this study of 32-36 years, 55.55% of these patient had only grade 1 
placental volume. In the contrary, 10 patients amount 11 in the age group 
of 18-22 had grade 3 placental volume. 
This is comparable with a study conducted  by Taj Muhammed, Asmat 
Ara (2010) who reported younger maternal age is a risk factor for IUGR 
by comparing with a study by Jamal et al, &Ferraz et al. 
4. COMPARISON OF PLACENTAL GRADING WITH 
PARITY: 
 When comparing the parity with placental volume grading the 
following findings were noted. 
PARITY GRADE 1 GRADE 2 GRADE 3 TOTAL 
PRIMI 20 19 10 49 
MULTI 34 16 1 51 
 
In our study even though both primi& multi were presented equally. 
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PLACENTAL GRADING AND PARITY 
 
 
 This diagram represents the comparison of placental grading 
with parity. Here primigravidas had severe reduction in placental volume 
when compared to multigravidas. This is comparable with the study by 
tajmohammed, Asmat Ara (2010) who reported the primiparity was also a 
significant risk factor for IUGR at  multivariable level. Similar findings 
was also reported byFikree et al &Thompsond et al. 
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PLACENTAL BED VASCULARITY INDEX 
 
 A Comparative analysis of PBVI revealed statistically 
significant differences between normal and IUGR pregnancies.In normal 
pregnancies PBVI is on range of 30 to 32 than IUGR(20 to 24) 
 VI was 6-8 times higher for normal than IUGR pregnancies.It 
clearly shows that placenta of IUGR has fewer blood vessels and 
decreased blood flow. 
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4. DOPPLER ANALYSIS: 
 All the patients in IUGR group were subjected to arterial 
Doppler & the cerebroplacental ratio was calculated. Venous Doppler 
was not done. The report were analysed based upon the Cerebroplacental 
ratio. 
CPR GOOD OUTCOME ADVERSE OUTCOME 
< 1 20 32 
> 1 31 17 
 
 In patients with CPR <1 the adverse outcome was more when 
compared with CPR>1. 
On analyzing the dates with placental volume grading following 
was observed. 
PLACENTAL 
VOLUME 
CPR <1 CPR>1 
GRADE 1 22 32 
GRADE 2 19 16 
GRADE 3 11 - 
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DOPPLER AND PLACENTAL GRADING 
 
This Shows that grade 1 placental volume is associated with less 
Doppler changes. All patients with Severe reduction in placental volume 
is associated with Doppler changes. 
This is comparable with the study done by Dudareniex L, 
kaluzewski B (2006) in which they compared placental volume with 
Doppler study in 82 pregnancies between 14-40 wks of gestation. They 
concluded that PI of umbilical artery correlated negatively with Placental 
volume, PI of MCA showed no significant correlation whereas the 
Cerebroplacental ratio showed significant positive correlation with 
placental volume. 
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 Good Outcome Adverse Outcome 
CPR <1 20 32 
% within CPR 39.2% 60.8% 
% within Outcome 38.8% 64.6% 
CPR >1 31 17 
% within CPR 65.3% 34.7% 
%within Outcome 61.5% 35.4% 
 
On statistical analysis of Doppler changes with perinatal outcome 
the following was noted. 
P= 0.009** Highly significant. (Pearsons chi-square test) 
DOPPLER AND PERINATAL OUTCOME 
 
 
 
 
 
 
 
This shows the sensitivity of predicting the perinatal outcome  by 
CPR is 60.08% and the specificity is 65.3% 
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5. The mode of delivery in patients with IUGR: 
All the patients in the study group were observed till delivery. Patients 
were followed up by antenatal fetal surveillance with daily fetal 
movement count, Non stress test,  modified Biophysical profile, weekly 
Doppler, serial ultrasound to monitor the interval profile, after decision 
for termination of pregnancy, placental volume again measured if it was 
done 48 hrs before, Bishop scoring, non stress test, Amniotic fluid index 
all were repeated. The mode of termination was decided based upon all 
these parameters, Those who were planned for vaginal delivery were 
induced with cerviprime gel & were carefully monitored for sign of fetal 
distress. 
MODE OF 
DELIVERY 
GRADE 1 GRADE 2 GRADE 3 TOTAL 
SPONTANEOUS 
VAGINAL 
DELIVERY 
1 1 - 2 
INDUCED 
VAGAINAL 
DELIVERY 
12 6 6 24 
CAESAREAN 
SECTION 
41 28 5 74 
TOTAL 54 35 11  
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Vaginal delivery was very low in all IUGR group irrespective of 
placental volume. Total no of caesarean section was high when compared 
to vaginal delivery. 
The indications of caesarean section were the following. 
INDICATIONS NO OF 
DELIVERY 
PRECENTAGE 
FAILED INDUCTION 32 43.24 % 
NON REASSRING CTG 23 31.08% 
SEVERE 
OLIGOHYDROMNIOS 
8 10.81% 
BREECH 11 14.86% 
 
  
MODE OF DELIVERY  
VAGI…
LSCS
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 Among these indications, failed induction was more in primi 
gravida with gestational age between 34-37 wks. This was mainly due to 
poor Bishop score at the time to induction. Some patients in the group of 
induction were taken up for LSCS for the signs of intrapartum fetal 
distress. In the Electronic fetal hart rate monitoring, the incidence of non 
reassuring heart rate pattern was observed more if the placental volume 
<10th percentile. The commonest non reassuring pattern observed was 
loss of beat variability followed by absence of accelerations. Spontaneous 
deceleration were observed in patients with very low placental volume. 
Severe oligohydramnios was also more in placental volume < 50
th
 
percentile. 
 Distribution of birth weight in the IUGR group. 
 The birth weight of the babies were compared with placental 
volume and  analysed. 
BIRTH 
WEIGHT 
PLACENTAL 
VOLUME 
GRADE 1 
PLACENTAL 
VOLUME 
GRADE 2 
PLACENTAL 
VOLUME 
GRADE 3 
TOTAL % 
<1KG - - 2 2 2% 
1-1.5 KG 6 2 9 17 17% 
1.6-2.0 20 27 - 47 47% 
2.1-2.5 % 28 6 - 34 34% 
 
 In grade 3 placental volume the birth weight of the babies was 
significantly lower than that of grade 1 and grade 2 placental volume. 
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PLACENTAL GRADING AND BIRTH WEIGHT 
 
This  diagram shows the birth weight distribution according to 
placental grading. Very low birth weight babies were observed in the 
group of severe reduction in placental volume. In patients with grade 1 & 
grade 2 placental volume, the birth weight was 1.6-2.5 kgs. This shows a 
positive correlation between placental volume  and birth weight. 
Placental volume Average birth weight S.D Significance 
Grade 1 1.99 kg 0.30 0.001 
Grade 2 1.82 kg 0.21 0.001 
Grade 3 1.25 kg 0.6 0.001 
 
P= 0.009** Highly significant. 
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When comparing the average birth weight of grade 1& grade 2 
placental volume, there was no significant difference between these two. 
When comparing that of grade 1 & grade 2 with grade 3 there was 
significant reduction in birth weight noted. 
This is comparable with a study done by Thame M, Osmond, 
Wilks (2001) in which they concluded that low birth weight was often 
preceded by small placental volume in second trimester. Placental  
volume may be a more reliable predictor of size at birth than fetal 
anthropometric measurements and may be useful in early identification of 
fetal with perinatal risk. 
The perinatal outcome of the babies are as follows 
The perinatal outcome of the babies in IUGR group are analysed 
and the results are as follows. 
PERINATAL 
OUTCOME 
PLACENTAL 
VOLUME 
GRADE 1 
PLACENTAL 
VOLUME 
GRADE 2 
PLACENTAL 
VOLUME 
GRADE 3 
% 
ADVERSE 10 18 11 39% 
GOOD 44 17 - 61% 
 
In patients with grade 1 placental volume, the outcome of the baby 
was good. 
74 
 
0
5
10
15
20
25
30
35
40
45
50
IUD LOW APGAR FETAL DISTRESS NND GOOD
perinatal outcome and placental grading 
PV GRADE 1 PV GRADE2 PV GRADE3
In patients  with grade 2 placental volume, both good and adverse 
outcome of the baby was equal. In patients  with grade 3 severe placental 
volume reduction, all babies had adverse outcome only. 
On analysing the adverse outcome the following was noted. 
PERINATAL 
OUTCOME 
PLACENTAL 
VOLUME 
GRADE 1 
PLACENTAL 
VOLUME 
GRADE 2 
PLACENTAL 
VOLUME 
GRADE 3 
TOTAL 
IUD   2 2 
LOW APGAR 
AT BIRTH 
6 10 3 19 
FETAL 
DISTRESS/M
SAF 
3 5 1 9 
EARLY 
NEONATAL 
DEATH 
1 3 5 9 
NO 
ADVERSE 
OUTCOME 
44 17  39 
 
 
 
 
 
 
75 
 
In patients with grade 1 placental volume the outcome of fetus was 
good.In this group  babies showed low APGAR at birth and 3 babies 
suffers fetal distress because of MSAF.Among this babies with perinatal 
morbidity,2 babies with meconium aspiration and 1 baby with low apgar 
at birth died in the early neonatal period after admission in the neonatal 
care unit.The other babies recovered well.babies had good perinatal 
outcome without any morbidity and mortality. 
In patients with grade 2 placental volume, the incidence of fetal 
distress and low apgar were more. Low APGAR noticed in 10 babies.The 
incidence of fetal distress with meconium aspiration was noticed in 5 
babies.Among these babies 3 babies with meconium aspiration syndrome 
and 2 babies with poor APGAR totally 5 babies died even with good 
neonatal critical care.other babies recovered well.17 babies had no 
adverse outcome.moreover 3 babies died in early neonatal period due to 
sepsis.The overall good outcome of babies in grade 2 placental volume 
when considering those babies recovered from initial perinatal morbidity 
was which is lower than grade 1 placental volume. 
In patients with grade 3 placental volume all babies had adverse 
outcome only.There was 2 IUD mainly due to severe IUGR and very low 
birth weight.3 babies born with low APGAR,1 baby with severe fetal 
distress due to meconium aspiration.all these babies died in the early 
neonatal period even with good intensive care unit after admission due to 
delayed complications like sepsis.The adverse outcome of the babies in in 
grade 3 placenta was 100% 
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On statistical analysis the following was observed 
Placental volume Good outcome Adverse outcome significance 
Grade 1 81.48% 18.52% .003 
Grade 2 48.57% 51.43%  
Grade 3  100%  
 
The percentage of good outcome in grade 1 placental volume was  
81.48% and for adverse outcome it was 18.52%. The percentage of good 
outcome in grade 2 placental volume was  48.57%    for adverse outcome 
it was  51.43%.This showed when the placental volume goes down there 
was an increase in adverse outcome. 
The percentage of adverse  outcome in grade 3 placental volume 
was  100%    .so it predicts poor perinatal outcome.This shows the 
positive correlation between placental volume and perinatal outcome. 
The average placental volume measured by usg and after delivery 
in IUGR group was 
GESTATIONAL 
AGE 
PV BY USG 
PV AFTER 
DELIVERY 
32-34 WKS 325 330 
35-37WKS 492 490 
38-40WKS 586 588 
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There was no significant difference noted between the placental 
volume measured before delivery by USG and that measured after 
delivery.This denotes placental volume measurement in the antenatal 
period is an effective method. 
The average placental volume in normal group before and after 
delivery was 
GESTATIONAL 
AGE 
PLACENTAL 
VOLUME BY 
USG 
PLACENTAL 
VOLUME AFTER 
DELIVERY 
32-34 WKS 490 496 
35-37WKS 594 600 
38-40 WKS 680 676 
 
In these group also both measurements were correlated well. 
This was comparable with the study by Humberto 
Azprurua,Edmund F who noticed significant correlation between 
placental volume measured by usg and placental volume measured after 
delivery. 
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SUMMARY 
This is a prospective analytical study. 
100 patients with singleton uncomplicated pregnancy selected as 
control .100 patients with singleton IUGR pregnancy were included in 
this study inorder to match the variables in IUGR group. 
85% of IUGR patients was in 32 to 37 weeks of GA.The common 
maternal age group is 31 to 36 years. 
General and obstetric examination done for all the patients.By 
doing USG fetal biometry including BPD,FL,AC,EFW,AFI were 
measured.Doppler study of umbilical artery and middle cerebral artery 
done .Cerebroplacental ratio calculated from resistance index of middle 
cerebral and umbilical artery for all the patients. 
Placental localization done.placental volume and placental bed 
vascularity measured. 
All patients followed uptodelivery.The mode of delivery and the 
indication for LSCS noted.Birthweight of the baby noted.All perinatal 
morbidities like MSAF,low APGAR was noted.All babies followed 
uptodischarge.placental volume again measured after delivery.The 
placental volume measured by ultrasound was compared with that 
measured after delivery.The results compared with normal pregnancy.The 
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average placental volume in normal pregnancy is 582.82cm3.Average 
placental volume in IUGR pregnancy was 400.91cm3. 
This shows significant difference in placental volume between 
these group.On statistical analysis,this showed significant 
difference.p=.001(highly significant:Levenes T-Test) 
The placental volume done by usg before delivery was compared 
that of measured after delivery.The average placental volume after 
delivery in IUGR group was 403.65cm3.The average placental volume 
measured after delivery in normal pregnancy was 592.20cm3.These did 
not shows much difference that of usg measurement before delivery. 
In normal pregnancies placental bed vascularity is on range of 30-
32 than IUGR(18-20) 
VI was 5-6 higher in normal pregnancy than IUGR.It clearly shows 
that placenta of IUGR has fewer blood vessels and decreased blood flow 
and placental insufficiency. 
The average birthweight of babies in grade 1 placental volume 
1.99kgs and in grade 2 placental volume is 1.82kgs.These 2 didn’t show 
much difference.The average birth weight in grade 3 placental volume is 
1.25kgs.This shows significant difference in average birth weight. 
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When the placental volume was compared with that of baby,in 
grade 1 placental volume,there was 81.48% good outcome and 18.52% 
adverse outcome and in grade 2 placental volume,the good outcome is 
48.57% and the bad outcome raised to 51.43% .In grade 3 placental 
volume 100%adverse outcome only.This shows the placental volume had 
good correlation with fetal outcome. 
This study shows positive correlation between the severity of 
IUGR and placental volume,placental bed vascularity.It predicts adverse 
perinatal outcome of the fetus.Hence this  can be taken as one of the 
methods of predicting adverse neonatal outcome in IUGR. 
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CONCLUSION 
Healthy baby and healthy mother is the goal of obstetrical 
management. 
The diagnosis of Uteroplacental insufficiency, the major cause of 
IUGR, identifies the group of fetuses who are at increased risk for 
perinatal complications. 
Ultrasonography plays a major role in early diagnosis of IUGR. 
Doppler ultrasonogram helps in identifying fetuses already in 
hypoxia and academia so that early interventions could be done to reduce 
perinatal complications. But it needs costly equipment and trained 
personale which limits its usefulness in developing country like India. 
Placental volume has positive correlation with birthweight of the 
baby and perinatal complication. 
Estimation of placental volume by simple 2 dimensional ultrasound 
could be a better alternative method of antenatal fetal surveillance in 
IUGR where Doppler ultrasound is not available. 
The quantitative assessment of placental volume and PBVI is an 
adjunctive modality for differentiation between normal and IUGR.The 
measurement of placental volume and PBVIin 1st and 
2n
d trimester of 
pregnancy enables identification of impaired trophoblast invasion and 
helps in predicting the development of IUGR and preeclampsia. 
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ANNEXURE I 
PROFORMA 
DATE: 
NAME : 
AGE: 
IP NO: 
SOCIOECONOMIC CLASS: 
RELIGION: 
OCCUPATION : 
ADDRESS & CONTACT NO: 
DOA: 
OBSTETRIC CODE: 
D.O. DELIVERY: 
DOD: 
History of present illness : 
Menstrual history: 
 
 
Regular Irregular 
LMP: 
EDD: 
Marital History: 
Married Since : 
Consanguinity: 
H/o Infertility: 
Obstetric History: 
Previous Obstetric History: 
Details of Outcome 
Personal History: 
Details of Outcome 
Personal History: 
Smoking – 
Alcohol- 
Diet – 
 
 
Past Medical History: 
Diabetes: 
Chronic Hypertension: 
Heart Disease: 
Others: 
Drug Intake: 
Others : 
Past Surgical History: 
Present Pregnancy: 
I Trimester: 
Hyperemesis 
Fever 
Radiation Exposure 
Medications 
Pain Abdomen 
 
 
 
II Trimester: 
Date of quickening 
Bleeding PV 
GDM 
Pre-eclampsia 
III Trimester: 
Bleeding Pv 
GDM 
Pre eclampsia 
GENERAL EXAMINATION 
Height : 
Weight : 
BMI: 
Built:       Thin :       Average :   Obese: 
Pallor/ jaundice/clubbing/pedal edema/cyanosis/lymphadenopathy 
Pulse : RR: 
 
 
Blood Pressure: 
Cardiovascular System: 
Respiratory System: 
Thyroid :     Breast: 
OBSTETRIC EXAMINATION 
Fundal height: 
FH: 
Liquor adequacy: 
PELVIC EXAMINATION: 
Investigations: 
Urine: Albumin 
Sugar 
Blood : 
Hemoglobin : 
Blood Sugar: 
Urea: 
 
 
S. Creatinine : 
Blood groupingand typing : 
HIV:      VDRL:   HBASg: 
Ultra Sound: 
BPD    
AC    
FL    
AFI    
EFW    
GA    
PLACENTA    
 
DOPPLER STUDY: 
UMBILICAL ARTERY RI: 
MIDDLE CEREBRAL ARTERY RI: 
CPR: 
 
 
PLACENTAL VOLUME: 
PLACENTAL BED VASCUARITY: 
DELIVERY: 
VAGINAL :   SPONTANEOUS:  
 INDUCED: 
LSCS :   ELECTIVE/EMERGENCY: 
OUTCOME: 
IUD/STILL BORN: 
BIRTH WEIGHT:     APGAR: 
LIQUOR:   CLEAR/MECONIUM: 
PLACENTAL VOLUME: 
 
 
 
 
 
 
 
ANNEXURE II 
CONSENT FORM 
I  agree to participate in the study entitled “COMPARATIVE STUDY 
OF USG ASSESMENT OF PLACENTAL VOLUME AND 
PLACENTAL BED VASCULARITY IN NORMAL PREGNANCY 
AND IUGR”  I confirm that I have been told about this study in my 
mother tongue and have had the opportunity to clarify my doubts. 
I understand that my participation  is voluntary and I may refuse to 
participate at any time without  giving any reasons and without affecting 
my benifits. 
I agree not to restrict the use  of any data or results that arise from this 
study. 
Name of the participant   : 
Sign / Thumb print   : 
Name of the investigator : Dr. A. KANIMOZHI 
Sign of Investigator   : 
  
 
 
ANNEXURE III 
ABBREVIATIONS 
 
 LSCS- Lower Segment Caesarean Section. 
 HSV – Herpes Simplex Virus 
 HIV – Human Immunodeficiency Virus 
 IUD – Intra Uterine Death 
 BMI – Body Mass Index 
 ACOG - American College of Obstetricians and Gynecologists 
 LBW – Low birth weight 
 PV – Placental Volume 
 PBVI – Placental Bed Vascularity Index 
 
 
 
 
 
 
 
  
 
 
ANNEXURE IV 
ETHICAL COMMITTEE APPROVAL FORM 
  
 
 
PLIAGRISM V 
 
 
 
Sl.No Name Age IP No Obst Code G/A(LMP) GA (USG) PV (USG)
PV 
(DELIVERY) PBVI DELIVERY BW OUTCOME
1 ZEENTH 17 9748 Primi 33-34 34-35 532 542 31.24 VAGINAL 2.4 LOWAPG
2 SANGEETHA 19 9695 Primi 34-35 34-35 580 590 30.14 VAGINAL 2.6 GOOD
3 VALLI 21 9731 Primi 34-35 33-34 590 580 32.34 LSCS 2.7 GOOD
4 SHALINI 22 9723 Primi 35-36 36-37 565 570 33.1 LSCS 2.5 RESP DISTRESS
5 VINITHA 19 9738 G2A1 34-35 35-36 568 550 30.12 VAGINAL 2.4 GOOD
6 SATHYA 20 9648 Primi 35-36 35-36 540 535 31.21 VAGINAL 2.5 GOOD
7 JOTHI 22 9713 G2P1L1 34-35 35-36 560 575 29.21 LSCS 2.6 GOOD
8 KAYATHIZHI 27 9717 G2P1L1 35-36 36-37 572 585 29.34 VAGINAL 2.7 GOOD
9 SADHANA 21 9683 G3P1P1L1A1 35-36 34-35 565 580 31.34 LSCS 2.9 GOOD
10 SUBHALAKSHMI 25 9798 Primi 35-36 36-37 555 570 33.14 VAGINAL 2.6 GOOD
11 RAMYA 22 9794 G2A1 34-35 34-35 545 560 29.24 VAGINAL 2.5 RESP DISTRESS
12 RADHA 25 9708 G2P1L1 36-37 36-37 585 592 28.91 VAGINAL 2.7 GOOD
13 DURGA 21 9729 Primi 35-36 36-37 590 585 29.14 LSCS 2.6 GOOD
14 ESTHER RANI 24 9349 Primi 34-35 35-36 540 555 28.34 VAGINAL 2.9 GOOD
15 GOMATHI 23 9809 G2A1 34-35 34-35 552 565 31.14 LSCS 2.8 GOOD
16 BHARANI 23 9801 G2P1L1 35-36 36-37 562 582 30.32 VAGINAL 2.7 GOOD
17 NAVEEN 28 9810 Primi 34-35 35-36 515 525 31.24 LSCS 2.4 LOWAPG
18 NALINI 29 9724 G3PIL2 35-36 34-35 546 555 33.14 VAGINAL 2.7 GOOD
19 DIVI 31 9819 G3P2L2 36-37 35-36 546 585 30.64 VAGINAL 2.9 GOOD
20 GAYATHIRI 30 9807 Primi 35-36 36-37 550 572 32.74 LSCS 2.8 GOOD
21 GEETHA 29 9354 G3P1L1A1 34-35 34-35 536 545 31.46 VAGINAL 2.3 RESP DISTRESS
22 NAGENI 27 9804 G2P1L1 35-36 34-35 542 565 32.64 VAGINAL 2.7 GOOD
23 ASHWINI 28 9814 G2P1L1 35-36 36-37 570 580 30.04 LSCS 2.8 GOOD
MASTER CHART- NORMAL PREGNANCIES
24 JAYASUDHA 26 9803 Primi 36-37 35-36 575 590 30.68 VAGINAL 2.5 MSAF
25 GAWRI 30 9797 G3P1L1A1 35-36 34-35 580 595 30.72 VAGINAL 2.7 GOOD
26 FARODJA 31 9730 G3P2L0 34-35 33-34 530 555 31.84 VAGINAL 2.6 GOOD
27 REVATHY 29 9743 G2A1 35-36 35-36 545 560 31.82 LSCS 2.5 GOOD
28 NADHIYA 31 9791 Primi 35-36 36-37 550 560 28.74 VAGINAL 2.6 GOOD
29 SILAMBARASI 34 9793 G3P2L2 34-35 33-34 525 540 28.72 LSCS 2.8 GOOD
30 NISHATHINI 31 9843 Primi 34-35 35-36 568 580 28.64 LSCS 2.7 GOOD
31 DIANA 33 9827 G2A1 36-37 35-36 575 570 28.61 LSCS 2.8 GOOD
32 SHIFANA 29 9836 G2A1 34-35 34-35 536 545 28.2 VAGINAL 2.5 GOOD
33 MAHALAKSHMI 31 12080 G2A1 34-35 35-36 535 542 29.73 LSCS 2.7 GOOD
34 SUDHA 31 12255 G3P2L2 35-36 36-37 542 555 29.73 VAGINAL 2.9 GOOD
35 SUMADHI 30 12261 Primi 34-35 35-36 515 525 30.14 VAGINAL 2.2 RESP DISTRESS
36 MEGALA 32 16678 G3P1L1A1 35-36 35-36 550 560 30.16 LSCS 2.6 GOOD
37 POORKODI 29 12077 G2P1L1 36-37 36-37 568 580 31.18 LSCS 2.9 GOOD
38 RANJITHA 28 12104 G3P1L1A1 36-37 36-37 572 585 30.68 VAGINAL 2.8 GOOD
39 RENUKA 31 12218 G2PILO 34-35 35-36 525 540 31.72 LSCS 2.7 GOOD
40 PREMA 32 12253 Primi 36-37 34-35 584 575 30.62 LSCS 2.7 GOOD
41 DEEPA 30 11942 G2P1L1 35-36 34-35 570 580 30.74 VAGINAL 2.6 GOOD
42 SABIYA 31 11472 Primi 34-35 36-37 538 545 32.7 VAGINAL 2.5 GOOD
43 MANJLA 34 11304 G3P1L1A1 35-36 33-34 574 590 32.62 LSCS 2.9 GOOD
44 MITHULA 33 11460 G3A2 35-36 34-35 563 570 31.84 LSCS 2.7 GOOD
45 BADHOUR NISHA 31 11470 G2P1L1 34-35 35-36 555 560 31.82 VAGINAL 2.8 GOOD
46 SATHIYAPRIYA 30 11355 G2A1 36-37 35-36 585 600 30.12 VAGINAL 2.9 GOOD
47 DEVAKRIBA 32 11453 G2P1L1 34-35 33-34 592 612 29.14 VAGINAL 3 MSAF
48 SHABA 33 11131 Primi 34-35 35-36 530 545 29.12 LSCS 2.6 GOOD
49 BARANI 29 11411 G2PILO 35-36 34-35 525 540 30.13 VAGINAL 2.4 GOOD
50 SEETHA 31 11488 Primi 33-34 34-35 548 565 31.16 VAGINAL 2.6 MSAF
51 VIJAYALAKSHMI 19 11433 Primi 36-37 36-37 605 640 31.13 LSCS 3.1 GOOD
52 VINODHIYA 20 11465 Primi 35-36 36-37 595 580 32.12 LSCS 2.9 GOOD
53 PRIYALAKSHMI 21 11417 Primi 36-37 36-37 580 570 33.12 VAGINAL 2.8 GOOD
54 SOWMEYA 22 11374 Primi 37-38 36-37 595 580 30.14 LSCS 2.9 GOOD
55 VALARMATHY 23 11471 G2A1 36-37 35-36 602 615 30.12 VAGINAL 3 GOOD
56 RAJITHA 25 11438 G2P1L1 37-38 37-37 600 620 29.12 VAGINAL 3.1 GOOD
57 FAYAZ 26 11434 Primi 36-37 35-36 592 610 29.14 LSCS 3 GOOD
58 LAKSHMI 25 11454 G2P1L1 36-37 35-36 584 580 30.16 VAGINAL 2.9 GOOD
59 HEMALATHA 27 11446 G2P1L1 36-37 37-38 575 602 30.12 VAGINAL 3.3 GOOD
60 ELIZABATH 28 11036 G3P1L1A1 36-37 37-38 610 625 30.14 VAGINAL 3.5 MSAF
61 ZAINAB 31 11317 Primi 35-36 34-35 595 585 30.16 VAGINAL 2.9 MSAF
62 DIVYA 29 11357 G2P1L1 36-37 35-36 582 590 31.12 VAGINAL 3 GOOD
63 VAISHALI 29 11240 G3P1L1A1 35-36 36-37 590 594 31.24 LSCS 2.8 GOOD
64 SIRUGANI 31 11239 G3A2 36-37 35-36 588 555 32.12 VAGINAL 3.2 GOOD
65 SUDARI 27 12399 G3P1L1A1 36-37 37-38 586 590 30.18 VAGINAL 3.2 GOOD
66 RAMYA 28 12338 G3P2L2 37-38 36-37 590 600 29.24 VAGINAL 3.3 GOOD
67 GEETHA 31 12396 Primi 37-38 38-39 598 615 29.2 LSCS 2.9 GOOD
68 DEVI 30 12259 Primi 36-37 37-38 565 585 31.12 3.2 MSAF
69 ANBUKARASI 32 11497 G2P1L1 36-37 35-36 575 590 30.13 VAGINAL 2.9 GOOD
70 ANJANI 32 11325 Primi 37-38 38-39 590 610 29.13 LSCS 3.4 MSAF
71 JANAKI 35 12300 G3P1L1A1 36-37 38-39 575 600 29.14 VAGINAL 3.1 GOOD
72 GAYATHIRI 34 12331 G2PILO 37-38 36-37 610 625 29.52 LSCS 3.2 GOOD
73 NIRMALA 34 12262 G3A2 36-37 37-38 587 602 30.54 LSCS 3.1 GOOD
74 LEAVASI 33 12298 G3P2L1 37-38 36-37 585 590 29.29 VAGINAL 3.2 GOOD
75 RANJAN 18 12980 Primi 36-37 37-38 625 633 30.31 VAGINAL 3.3 GOOD
76 NILO 20 12188 Primi 38-39 37-38 625 640 29.3 LSCS 3.1 GOOD
77 USHA 19 12348 G2A1 38-39 39-40 635 650 29.13 VAGINAL 3.2 LOWAPG
78 RAMYA 23 12223 Primi 37-39 38-39 604 615 30.14 VAGINAL 3.1 GOOD
79 PREMA 25 12268 Primi 37-38 36-37 610 625 32.16 VAGINAL 3.3 GOOD
80 DHANA 32 12311 G3A2 37-38 38-39 598 615 30 VAGINAL 3.1 GOOD
81 ANITHA 23 12067 G2P1L1 37-38 37-38 625 640 31 LSCS 3.2 GOOD
82 VANI 37 12330 G3P1L1A1 38-39 38-39 640 625 30.13 VAGINAL 2.9 MSAF
83 MEGALA 28 12354 Primi 38-39 37-38 625 610 30.16 LSCS 3 MSAF
84 AFRIA 31 12411 Primi 37-38 37-38 590 610 30.18 VAGINAL 3.1 GOOD
85 AMUL RANGANAYAGI 30 12406 G2P1L1 38-39 38-39 610 600 31.28 VAGINAL 2.9 GOOD
86 USHA 29 12632 G2A1 37-38 36-37 610 625 32.38 VAGINAL 3.1 LOWAPG
87 PADMINI 29 12385 Primi 37-38 37-38 588 602 33.48 LSCS 3.2 GOOD
88 KALAYARASI 32 12410 G2A1 37-38 36-37 595 615 30.32 VAGINAL 3.2 LOWAPG
89 RASIDHA 31 12375 G3P2L2 38-39 37-38 625 610 30.52 VAGINAL 3.1 LOWAPG
90 UMADEVI 32 12388 G2P2L2 38-39 37-38 625 640 30.54 VAGINAL 3.5 GOOD
91 RADHA 33 12408 G3P1L1A1 37-38 38-39 610 625 29.62 LSCS 3.1 GOOD
92 MANIPRIYA 32 12296 G3A2 38-39 37-38 620 635 30.64 VAGINAL 3.25 MSAF
93 MABUNISHA 35 12344 G2P1L1 37-38 36-37 600 625 31.72 VAGINAL 3.1 GOOD
94 PREAMILA 36 12356 G3P1L1A1 38-39 38-39 626 645 30.45 VAGINAL 3.25 GOOD
95 GIRIJA 36 12288 G2P1L1 39-40 38-39 680 695 30.42 LSCS 3.6 GOOD
96 KAMALI 34 12584 G2A1 38-39 38-39 676 695 30.4 VAGINAL 3.4 GOOD
97 REVATHY 31 12562 Primi 39-40 38-39 680 665 30.43 LSCS 3.6 GOOD
98 MANO RANJITHA 34 12572 Primi 38-39 38-39 685 680 31.2 LSCS 3.75 MSAF
99 NAYAGI 30 12494 Primi 39-40 38-39 680 665 31.35 LSCS 3.2 GOOD
100 MUBEEN 34 12483 G3A2 39-40 39-40 680 675 32.2 LSCS 3.3 GOOD
Sl.No Name Age IP NO Obst Code G/A(LMP) GA (USG)
MCA 
(RI) UA (RI) CPR PV (USG)
placental 
Maturity
PV 
(DELIVER PBVI DELIVERY IND BW OUTCOME
1 PREMKUMARI 19 9524 Primi 33-34 25-26 0.6 0.7 <1 184(III) (III) 174 22.22 LSCS OLIGO 1.1 NND 
2 VINODHINI 22 9637 G2A1 34-35 28-29 0.65 0.74 <1 195(III) (III) 190 20.12 LSCS FAIL IND 1.2 LOWAPG
3 RAJESHWARI 21 9554 G2PILI 34-35 27-28 0.64 0.76 <1 174(III) (III) 168 16.4 VAGINAL 840gms IUD
4 VIJAYALAKSHMI 21 9518 Primi 33-34 30-31 0.7 0.8 <1 190(III) (III) 196 18.4 LSCS OLIGO 1.6 LOWAPG
5 JAYAVEERA 19 9665 Primi 34-35 24-25 0.7 0.96 <1 160(III) (III) 150 16.1 VAGINAL 850GMS IUD
6 JAYALAKSHMI 19 9619 Primi 34-35 26-27 0.6 0.75 <1 185(III) (III) 195 19.2 LSCS FAIL IND 1.4 LOWAPG
7 NITHYA 23 9644 Primi 35-36 30-31 0.8 7 >1 325(II) (II) 315 28.12 VAGINAL 1.7 GOOD
8 JANSIRANI 24 9646 G2A1 34-35 29-30 0.76 0.64 >1 340(III) (III) 325 26.14 VAGINAL 1.9 GOOD
9 BHARANI 23 9657 G2PILI 34-35 32-31 0.7 0.8 <1 330(II) (II) 325 26.13 LSCS OLIGO 1.7 GOOD
10 PRASANA ROJA 26 9617 G2A1 34-35 32-31 0.7 0.68 >1 315 (II) (II) 303 25.11 LSCS BREECH 1.6 GOOD
11 SAMDHANI 25 9296 Primi 34-35 28-29 0.8 0.9 <1 324 (II) (II) 335 20 LSCS OLIGO 1.8 LOWAPG
12 RAJALAKSHMI 26 9518 G2PILO 34-35 31-32 0.7 0.82 <1 338(II) (II) 330 21 LSCS FAIL IND 1.4 LOWAPG
13 INDHUMATHI 24 9582 G2ILO 35-36 32-33 0.7 0.82 <1 345(II) (II) 360 23.5 LSCS FAIL IND 1.8 GOOD
14 YASODHA 25 9667 G2A1 36-37 31-32 0.9 0.8 >1 350 (II)  (II) 355 23.6 LSCS BREECH 1.5 GOOD
15 SARANYA DEVI 21 9502 G3PILIAI 34-35 30-31 0.86 0.74 >1 364(I) (I) 374 23.7 VAGINAL 1.5 GOOD
16 DEVI 22 9692 G3PILIAI 32-33 30-31 0.8 0.74 >1 346 (II)  (II) 340 20 LSCS FAIL IND 1.9 LOWAPG
17 SHYAMALA 29 9661 Primi 34-35 32-33 0.8 0.72 >1 412(1) (I) 398 28 LSCS FAIL IND 2 LOWAPG
18 DHILAGA 26 8276 G3PIL2 35-36 32-31 0.9 0.82 >1 328 (II)  (II) 325 28.14 LSCS OLIGO 2.1 GOOD
19 JAVAHARSARTHANI 28 9699 G4PILIA2 34-35 30-31 0.7 0.8 <1 315 (II)  (II) 324 29.3 LSCS BREECH 1.9 LOWAPG
20 POORNIMA 31 9611 Primi 35-36 31-32 0.7 0.68 >1 320(II) (II) 312 24.6 LSCS OLIGO 1.8 GOOD
21 VAHITHA 23 9710 G2PIL1 34-35 32-31 0.8 0.9 <1 300 (II)  (II) 315 22.1 LSCS BREECH 1.5 LOWAPG
22 SUMAYA 28 9695 Primi 34-35 32-33 0.7 0.68 >1 486 (I)  (I) 280 21.3 LSCS FAIL IND 1.8 LOWAPG
23 BISWAJITH 21 9641 Primi 34-35 31-32 0.8 0.7 >1 315 (II)  (II) 495 24 LSCS BREECH 2 GOOD
24 RADHA 31 9655 G5PIL1A2 35-36 31-32 0.8 0.7 >1 350 (II)  (II) 305 25.16 LSCS FAIL IND 1.9 GOOD
25 GOMATHY 30 9630 Primi 35-36 35-36 0.8 0.74 >1 424(I) (I) 412 26.12 LSCS FAIL IND 2.1 GOOD
26 JAYANTHI 29 9512 G2PIL1 35-36 35-36 0.8 0.84 <1 268 (II)  (II) 250 26.34 LSCS FAIL IND 2 GOOD
27 BHAVATHI 26 9577 Primi 34-35 34-35 0.8 0.76 >1 475 (I)  (I) 482 21 LSCS OLIGO 1.8 LOWAPG
28 FARZANA 29 9676 Primi 34-35 34-35 0.7 0.84 <1 328 (II)  (II) 345 26.4 LSCS FAIL IND 1.9 GOOD
29 RAMYA 32 9725 Primi 32-33 32-33 0.7 0.68 <1 384(I) (I) 364 19 LSCS 1.4 NND
MASTER CHART- IUGR PREGNANCIES
30 JEEVITHA 30 9588 G3P2LO 35-36 35-36 0.82 0.74 >1 480 (I) (I) 500 23 VAGINAL BREECH 2 GOOD
31 MANIBALA 34 9742 G2P1LO 33-34 33-34 0.84 0.76 >1 494(I) (I) 520 23.14 LSCS FAIL IND 2.1 GOOD
32 NAGALAKSHMI 33 9295 G4PILIA2 36-37 36-37 0.8 0.76 >1 502 (I)  (I) 535 24.26 LSCS FAIL IND 2.3 GOOD
33 SHILPA 36 9447 Primi 33-34 33-34 0.76 0.84 <1 325 (II)  (II) 330 21 LSCS 2.1 LOWAPG
34 KALAIVANI 35 9714 G2A1 32-33 32-33 0.8 0.76 >1 326 (II)  (II) 330 22 VAGINAL FAIL IND 1.8 LOWAPG
35 YAUVARANI 35 9679 Primi 34-35 34-35 0.7 0.96 <1 384(I) (I) 334 17.4 LSCS FAIL IND 1.4 NND
36 PENERDEVI 32 12209 G3PILIAI 33-34 33-34 0.8 0.76 >1 315 (II)  (II) 320 19.2 LSCS FAIL IND 1.6 LOWAPG
37 NALINI 33 12245 G2A1 35-36 35-36 0.8 0.72 >1 512(I) (I) 540 24.6 LSCS 2.1 GOOD
38 DEVI 33 12277 G2PILI 34-35 34-35 0.9 1.1 <1 270(II) (II) 295 24.8 VAGINAL 2.2 GOOD
39 GAYATHIRI 35 11434 G3P2L2 34-35 34-35 0.8 0.96 >1 383 (I)  (I) 400 26 VAGINAL OLIGO 2 GOOD
40 PRIYANKA 34 11900 G3PILIAI 34-35 34-35 0.9 0.86 >1 254 (II)  (II) 275 19.2 LSCS FAIL IND 1.7 LOWAPG
41 JAYEEHIBE 32 11427 Primi 34-35 34-35 0.74 0.86 <1 325(II) (II) 330 23 LSCS 2.2 GOOD
42 SARANYA DEVI 33 12219 G2A1 34-35 34-35 0.7 0.84 <1 320(II) (II) 308 24.6 VAGINAL 2.1 GOOD
43 MALAR 36 12039 G2P1L1 34-35 34-35 0.7 0.72 <1 325 (II)  (II) 335 25.6 VAGINAL CTG NR 1.7 GOOD
44 VIDHYA 35 12209 G3PILIAI 34-35 34-35 0.8 0.76 >1 366 (I)  (I) 350 25.2 LSCS FAIL IND 1.9 GOOD
45 MAHASWARI 33 12245 G3A2 34-35 34-35 0.84 0.76 <1 386 (I)  (I) 395 25.24 LSCS FAIL IND 2 GOOD
46 BHRATHI 34 12277 G2PILI 34-35 34-35 0.76 0.86 <1 284(II) (II) 244 19.2 LSCS FAIL IND 1.6 NND
47 MICHAEL 32 11432 Primi 35-36 35-36 0.7 0.86 <1 416 (I)  (I) 440 24.12 LSCS BREECH 1.9 GOOD
48 SHANDHINI 30 12228 G2PILI 35-36 35-36 0.76 0.68 >1 505(I) (I) 525 24.72 LSCS BREECH 2.1 GOOD
49 PEIRAVAI 31 12189 G3P2LO 35-36 30-31 0.68 0.84 <1 288(II) (II) 271 18.14 LSCS CTG NR 1.7 LOWAPG
50 MALTHY 32 12165 G2PILI 34-35 32-33 0.82 0.76 >1 330 (II)  (II) 345 19.2 LSCS CTG NR 1.8 LOWAPG
51 LAKSHMI 35 12173 Primi 35-36 32-33 0.96 0.73 >1 412(II) (II) 418 28 VAGINAL 2.1 GOOD
52 KAMAL 36 12241 Primi 36-37 33-34 0.8 0.76 >1 492(I) (I) 510 24 VAGINAL 2 GOOD
53 SASIKALA 21 12246 Primi 35-36 34-35 0.74 0.76 <1 186(III) (III) 188 20.1 VAGINAL 1.2 NND
54 ISHWARYA 22 12260 Primi 36-37 30-31 0.8 0.96 <1 190 (III) (III) 210 20.34 LSCS CTG NR 1.3 MSAF
55 NAGALAKSHMI 20 11925 G2AI 36-37 33-34 0.8 0.76 >1 366 (II)  (II) 375 24.23 LSCS FAIL IND 2.1 GOOD
56 VASANTHI 24 11105 G2PILI 35-36 33-34 0.72 0.86 <1 584(II) (II) 590 25.2 LSCS CTG NR 2.2 GOOD
57 ELIZBETH 27 12006 G3PILIAI 36-37 33-34 0.86 0.7 >1 590 (I)  (I) 605 26.34 VAGINAL 2 GOOD
58 JEEVA 29 12005 G3A2 36-37 34-35 0.96 0.72 >1 582 (I)  (I) 575 22.34 VAGINAL 2.3 GOOD
59 VEERAMMAL 28 12003 Primi 36-37 34-35 0.92 0.76 >1 586 (I)  (I) 575 23.34 LSCS BREECH 1.9 GOOD
60 ARCHANA 24 11968 G2PILI 36-37 32-33 0.76 0.92 <1 544(I) (I) 562 23.62 LSCS CTG NR 2 GOOD
61 MARY 30 11974 G4PILIA2 36-37 33-34 0.8 0.76 >1 344 (II)  (II) 360 23.72 LSCS FAIL IND 2.2 GOOD
62 ANBU DEVI 31 11727 Primi 37-38 33-34 0.78 0.96 <1 572 (I)  (I) 580 21.22 LSCS FAIL IND 2.3 MSAF
63 JEEVITHA 22 11800 G2AI 35-36 31-32 0.9 0.8 <1 560(I) (I) 590 23.14 VAGINAL 2 GOOD
64 MAGESWARI 28 11937 Primi 37-38 34-35 0.96 0.72 <1 586 (I) (I) 600 23.16 VAGINAL 2.4 GOOD
65 GIRIJA 26 11980 Primi 37-38 32-33 0.86 0.73 >1 550 (I)  (I) 575 21.12 VAGINAL 2.3 MSAF
66 KAVITHA 32 11975 G2PILI 36-37 32-33 0.8 0.76 <1 550(I) (I) 540 22.34 LSCS BREECH 2.1 GOOD
67 JESIPHIRE 33 11932 Primi 36-37 31-32 0.76 0.84 <1 320 (I) (I) 335 20.62 LSCS FAIL IND 2 MSAF
68 JENIFER 35 14114 Primi 35-36 31-32 0.8 0.72 <1 335 (II)  (II) 340 23.46 LSCS FAIL IND 2.1 GOOD
69 SUBITHA 33 11882 G2PILI 36-37 31-32 0.9 0.72 >1 520(I) (I) 524 21.64 LSCS CTG NR 1.9 MSAF
70 JENIFER 32 11932 G3A2 37-38 32-33 0.74 0.96 <1 540 (I) (I) 550 21.2 LSCS BREECH 1.8 GOOD
71 JAUANJI 31 11970 Primi 36-37 30-31 0.74 0.82 <1 474(II) (II) 432 20.18 LSCS FAIL IND 1.6 LOWAPG
72 PRIYANKA 32 11981 G3P2L2 37-38 30-31 0.88 0.78 >1 440(I) (I) 450 21.32 VAGINAL 2.2 LOWAPG
73 SUDHA 36 11954 G2PILI 36-37 31-32 0.76 0.92 <1 446(I) (I) 450 20.42 LSCS FAIL IND 1.7 MSAF
74 JENIFER 35 11799 G2PILO 36-37 30-31 0.92 0.86 >1 394(II) (II) 398 18.42 LSCS CTG NR 1.2 NND
75 JAYANJI 33 11932 Primi 37-38 30-31 0.78 0.88 <1 415(I) (I) 410 21.14 LSCS CTG NR 1.4 MSAF
76 PRIYANKA 32 11882 G2PILI 36-37 29-30 0.74 0.88 <1 400(I) (I) 412 22.12 LSCS CTG NR 1.6 LOWAPG
77 NANDHINI 18 11774 Primi 37-38 30-31 0.8 0.92 <1 202 (III) (III) 195 19.74 VAGINAL 1.3 NND
78 ASMA 20 11513 Primi 37-38 31-32 0.96 1.2 <1 198 (III)  (III) 210 20.12 VAGINAL 1.25 NND
79 PVEETHI 24 11784 G2A1 36-37 31-32 0.82 0.76 >1 420 (I)  (I) 430 20.14 LSCS CTG NR 1.5 MSAF
80 GORETHY 24 11778 Primi 36-37 33-34 0.84 0.76 >1 430(I) (I) 415 21.12 LSCS CTG NR 1.7 MSAF
81 SHAHIN 28 11726 G2PILI 37-38 34-35 0.82 0.76 >1 465(I) (I) 475 24.43 LSCS CTG NR 1.8 GOOD
82 SURYAKAK 27 11728 G2AI 37-38 32-33 0.68 0.78 <1 322(I) (I) 330 20.12 VAGINAL 1.5 MSAF
83 JAYASRI 29 11727 G3PILIAI 37-38 31-32 0.72 0.86 <1 410 (I)  (I) 420 21.34 LSCS CTG NR 1.4 LOWAPG
84 DHIVYA 31 11767 G2PILI 36-37 34-35 0.82 0.84 >1 550(I) (I) 560 24.6 LSCS FAIL IND 2.2 GOOD
85 ASTALAKSHMI 31 11765 G2PILO 36-37 30-31 0.72 0.76 <1 340 (I)  (I) 350 21.12 LSCS CTG NR 1.6 MSAF
86 USHA 29 11572 Primi 37-38 33-34 0.82 0.84 >1 490 (I) (I) 500 24.13 LSCS CTG NR 1.8 GOOD
87 THANMOZHI 32 11318 G3PILIAI 37-38 34-35 0.78 0.76 <1 484(I) (I) 472 24.72 LSCS CTG NR 1.9 GOOD
88 VANISRI 31 11508 Primi 37-38 34-35 0.86 0.86 >1 501(I) (I) 496 26.72 LSCS CTG NR 2 LOWAPG
89 SUBHA 36 11791 G2PILI 37-38 32-33 0.84 0.75 >1 475(I) (I) 485 25.12 LSCS FAIL IND 1.7 LOWAPG
90 SEETHA 35 11416 G4PILIA2 36-37 31-32 0.74 0.78 <1 476(I) (I) 464 25.62 LSCS FAIL IND 1.8 GOOD
91 NARMADHALAKSHMI 34 11318 Primi 36-37 33-34 0.68 0.88 <1 492(I) (I) 480 25.64 LSCS FAIL IND 1.9 GOOD
92 BHAVANI 33 11656 G4PI2L2A1 38-39 34-35 0.74 0.82 >1 524(I) (I) 522 28.12 LSCS CTG NR 2.2 GOOD
93 KALPANA 32 11572 G2PILI 37-38 35-36 0.86 0.76 >1 565 (I)  (I) 579 22.12 LSCS BREECH 2.4 GOOD
94 PENAYAGAI 29 11667 G2PILO 37-38 33-34 0.86 0.72 >1 440 (I) (I) 450 20.12 LSCS CTG NR 1.4 LOWAPG
95 SARANYA DEVI 32 11675 Primi 38-39 30-31 0.64 0.88 >1 200(III) (III) 214 20.14 VAGINAL 1.3 NND
96 NANDHINI 35 11615 Primi 38-39 34-35 0.86 0.74 >1 630 (I) (I) 640 2.16 LSCS CTG NR 2.1 GOOD
97 THARA 34 11666 G3P2L2 39-40 35-36 0.76 0.84 >1 644(I) (I) 620 26.28 LSCS CTG NR 2.3 MSAF
98 RANI 27 11353 G3PILOA1 39-40 35-36 0.74 0.88 >1 675 (I)  (I) 675 27.28 VAGINAL 2 MSAF
99 KAVITHA 28 11492 G2A1 38-39 36-37 0.88 0.72 >1 680 (I)  (I) 690 28.46 VAGINAL 2.5 GOOD
100 UMA 30 11135 Primi 39-40 35-36 0.82 0.76 >1 540(I) (I) 575 28.44 LSCS CTG NR 2.4 GOOD
